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Abstract 
The metabolic effects of bovine growth hormone was studied in intact tilapia. Five 
daily intramuscular injections of bovine! growth hormone (50 ug/ 100 g fish/ injection) 
) 
significantly elevated serum levels of glucose and amino acid and decreased liver glycogen 
content and glycogen synthetase activity. There were no significant changes in serum 
concentrations of protein, total lipids and cholesterol and liver content of protein and lipid. 
Specific i25l-bGH and ^^^I-tGH binding to tilapia liver membranes was detected. 
Tilapia prolactin was much less potent than tilapia growth hormone in inhibiting the binding 
of 1251 �G H or I-tGH to tilapia liver membranes or solubilized liver membrane proteins, 
suggesting the existence of separate binding sites for prolactin and growth hormone in 
tilapia liver. Treatment of tilapia liver membranes with the thiol group reactive reagent p-
chloromercuribenzene sulphonate (PCMBS) significantly reduced specific binding of 
tilapia growth hormone and this inhibition could be reversed by dithioerythritol (DTE) 
treatment, indicating that a reactive sulphydryl group was involved in the tilapia 
somatogenic receptor. Treatment of tilapia liver membranes with trypsin and chymotrypsin 
reduced specific binding of ^ ^^ I-tilapia growth hormone, however, treatment with DNase, 
RNase and neuraminidase had no effect, implying that the growth hormone binding site was 
a protein and that sialic acid and nucleic acids was not involved in growth hormone binding. 
Solubilization of tilapia hepatic growth hormone-binding site was achieved by using 
the non-ionic detergent Triton X-100. Partial purification and characterization of this 
hepatic growth hormone-binding site was attempted. Its apparent molecular weight was 
i 
estimated to be about 400 K. It was adsorbed to Con A-Sepliarose suggesting ihal it was 
glycoprotein in nature and adsorbed to DEAE-BioGel A indicating that it was acidic in 
I „ 
character. An attempt to purify tilapia hepatic growth hormone receptor by a procedure' 
involving membrane solubilization, affinity chromatography on Con A-Sepharose, ion-
exchange chromatography on DEAE-BioGeJ A and gel filtration on Sepharose 4B yielded 
a preparation which showed a 3-fold increase in specific binding activity over the sokibilized 
liver membrane proteins. However the preparation was still heterogenous as revealed by 
sodium dodecyl sulphate-polyacrylamide gel electrophoresis. 
Somatomedin C-like immimoreactivity was detected in tilapia serum, as well as in 
various tissues including the liver, kidney, gonad, spleen，intestine, brain and muscle. The 
level of somatomedin C-like immunoreactivity was very low in the pituitary but high in the 
liver. The serum somatomedin C-like immunoreactivity was attributed to two fractions, one 
with a molecular weight of 9 K and another a molecular weight of 45 K. 
The effects of salinity and diet on somatic growth and hormones secretion were 
investigated. The increase in body weight was the highest in fish cultured in 50 % seawater 
and a reduction in body weight was observed in fish cultured in 100 % seawater. Fish fed 
more food in the diet had a higher growth rate. The highest serum growth hormone 
concentration was observed in fish cultured in 100 % seawater but the serum somatomedin 
C level was not the highest. Serum Cortisol level increased as the ambient salinity increased 
and decreased as the amount of food in the diet increased. The changes in serum thyroxine 
and insulin levels could not be correlated with the salinity changes. The results suggest 
that the highest growth rate of tilapia in 50 % seawater could not be explained by secretion 
ii 
of growth hormone, somatomedin C and insulin or minimal secretion of Cortisol. The body 
weight loss observed in tilapia cultured in 100 % seawater was probably due to the maximal 
secretion of the catabolic hormone Cortisol together with the osmotic stress in the high 
salinity. The maximal serum growth hormone concentration in this group of fish was 
probably a result of the stimulatory effect of Cortisol on growth hormone secretion. T h e 
lack of response of serum somatomedin C may be attributed to multifarious regulation of 
somatomedin C production or a defect somewhere between hepatic binding of growth 
hormone and hepatic production of somatomedin C. Serum sodium ion level increased but 
serum potassium ion level decreased as the ambient salinity increased suggesting a 
counterflow of the two ions in osmoregulation. The energy expenditure for osmoregulation 
in different ambient salinities may play a critical role in determining the growth rate of 
tilapia. Other factors such as changes in activities of digestive enzymes and rate of 
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b G H Bovine growth hormone 
B S A Bovine serum albumin 
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I-tPRL lodinated tilapia prolactin 
IGF-I Insulin-like growth factor-I 
IGF-II Insulin-like growth factor-II 
K+ Potassium ion 
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� 4 Thyroxine 
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Objectives of the study 
To study the metabolic effects of bovine growth hormone, to characterize the growth 
hormone-binding sites and somatomedin C-like immunoreactivity, and to investigate the 
effects of salinity and diet on somatic growth and secretion of hormones in a freshwater 
teleost，Oreochromis mossambicus. 
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Chapter 1 General Introduction 
Physicochemical characterization of growth hormone 
Growth hormone (GH) was first discovered as a growth-promoting substance in 
bovine pituitary extract which produced gigantism in rats (Evans and Long, 1921). After 
the pioneer work of Li and Evan (1944)，who first isolated a highly purified growth 
hormone of bovine origin, the isolation of growth hormones from other vertebrates was 
attempted. Growth hormones have been isolated from a variety of mammals, such as 
human and monkey (Li and Papkoff, 1956)，rat (Reisfeld et al.，1964)，rabbit (Ellis et al.， 
1968)，sheep, whale and pig (Papkoff et al., 1958a, 1958b, 1962), dog (Wilhelmi, 1968) and 
horse (Saxena and Henneman, 1966). The amino acid sequences of various growth 
hormones have been determined either 'from the purified proteins or from the c D N A of 
growth hormones. Mammalian growth hormone was found to be a single-chain polypeptide 
hormone containing 180-200 amino acids. Human growth hormone contained 2 intrachain 
disulfide bonds. A large loop formed by a disulfide bond between cysteine 53 and cysteine 
165 and another loop is found near the carboxyl terminal between cysteine 182 and cysteine 
189 (Parsons, 1976). It is rich in leucine, glutamate and aspartate residues. About 50-60 
% of the polypeptide chain is in a-helix structure. It has a molecular weight of 21.5 K. 
Comparison of amino acid sequences of growth hormones from different mammalian 
species showed different degree of variation (Nicoll et al” 1986). The percentages of 
homology between human growth hormone and bovine growth hormone, ovine growth 
hormone and equine growth hormone is 95 % , 91 % and 65% respectively (Paladini et al., 
1983). 
1 
Growth hormone exists in all classes of vertebrates and has been conserved with 
respect to amino acid content (Nicoll, 1986，1987). Growth hormones have been isolated 
from non-mammalian vertebrates, such as chicken, duck, pigeon and turkey (Farmer et 
al.，1974)，green sea turtle, snapping turtle, bullfrog and leopard frog (Farmer et al.，1976a) 
as well as fish, such as tilapia (Farmer et al., 1976b)�chum salmon (Komourdjian and Idler, 
1979)，carp (Miyazima et al.，1986)，shark (Lewis et al, 1972)，bonito (Noso et al, 1988) 
and eel (Kishida et al, 1987). The amino acid sequences and nucleotide sequences of 
growth hormones were studied on a comparative basis to provide a good subject for一 
structure-function relationship and molecular evolution of protein and peptide hormones 
(Nicoll et al, 1986). After the explosive progress in genetic engineering in the 1970�s，the 
primary structures or c D N A sequences of growth hormones from chum salmon (Sekine et 
1 
al, 1985)，coho salmon (Nicoll et al., 1987，Gonzales-Villasenor et al., 1988)，eel 
(Yamaguchi et al” 1987)，rainbow trout (Agellon and Chen, 1986), tilapia (Rentier-Delrue 
et al, 1989)，tuna (Sato et al, 1988) and yellow tail (Watabiki et al, 1988) had been 
reported. Comparison of amino acid sequences of different growth hormones showed that 
tilapia growth hormone (tGH) was 89% and 84.5 % identical to tuna and yellow tail growth 
hormones, respectively, but only 66 % identical to rainbow trout and chum salmon growth 
hormones (Rentier-Delrue et al, 1989). Identities of yellow tail G H with G H s from other 
animals are as follows : 66.3 % with chum salmon G H , 42.2 % with eel G H , 37.2 % with 
bovine G H and 34.2 % with human G H (Watahiki et al, 1988). Similarly, the amino acid 
sequence homologies between chum salmon G H and human G H was only 37 % (Kawauchi 
et al, 1986). Bonito G H was 93 % identical with tuna G H , 87 % with yellow tail G H , 69 
% with chum salmon G H , 42 % with eel and shark GHs, 38 % with sea turtle G H , 36-38 
2 
% with chicken and bovine GHs, 32 % with human G H . The overall amino acid sequence 
homologies between fish G H and mammalian G H was about 30-40 % . Application of the 
gene transfer technique in fish had been successful, and it was applicable to a number of 




Biological activities of growth hormone 
I 
The principle action of growth hormone was first discovered by Evans and Long 
(1921) that gigantism in rats was produced after repeated intraperitoneal injections of an 
emulsion of the anterior lobe of bovine pituitary . Growth hormone promotes overall 
somatic growth (Cheek and Hill, 1975), especially in skeleton and muscle. Growth hormone 
enhances longitudinal bone growth by stimulating cell division of chondrocytes and 
production of cartilage matrix components. Growth hormone also stimulates the growth 
in width of the tibial epiphyses in hypophysectomized rats. It has been used as an in vivo 
bioassay for growth hormone, known as the tibia test. 
Another action of growth hormone is the protein anabolic effect which produces a 
positive nitrogen and phosphorus balance, a rise in plasma phosphorus, and a fall in the 
blood urea nitrogen and amino acid levels. These effects may be due to a stimulation of 
protein synthesis in liver and skeletal muscle. Growth hormone can stimulate amino acid 
incorporation into proteins and membrane transport of amino acids and sugars into skeletal 
muscle, both in vivo and in vitro when the hypophysectomized rat is used as the 
experimental animal (Kostyo and Nutting, 1975). Growth hormone also has biological 
actions on lipid and carbohydrate metabolism. Growth hormone exerts both acute insulin-
like and chronic anti-insulin-like effects on carbohydrate and lipid metabolism (Davidson, 
3 
I 
1987). The acute insulin-like effect of growth hormone causing hypoglycemia and decrease 
I 
ill serum free fatty acids level is transient and mild, occurring within one hour after 
treatment. The chronic anti-insulin-like effects of growth hormone take place only after a 
lag period of 2-4 hours, producing hyperglycemia and an increase in serum free fatty acid 
level which is a result of lipolysis. 
Growth hormones exhibit species specificity. All mammalian growth hormones are 
potent in the rat tibia assay. Highly purified avian (Farmer et al.，1974)，reptilian and 
amphibian growth hormones (Farmer et al.，1976a) are also active in the rat tibia assay but 
with lower potencies, whereas fish growth hormones have a very low potency in the assay. 
Non-primate growth hormones are not active in man and monkey. Human growth 
hormone, but not other mammalian growth hormone, possesses lactogenic activity in 
addition to its somatogenic activity. 
Growth hormone has been shown to be effective in promoting growth not only in 
mammals, but also in fish. Mammalian growth hormone could stimulate growth in intact 
coho salmon (Higgs et al, 1975，1976; Markert et al, 1977)，Atlantic salmon (Komourdjian 
et al” 1976) and hypophysectomized rainbow trout (Komourdjian et al, 1978). 
Recombinant bovine growth hormone could accelerate growth in juvenile coho salmon (Gill 
et al, 1985) and coho salmon in the post-smolt stage (transition to seawater) and in the 
winter season (Down et al, 1988). Teleosts and elasmobranchs also secrete a hormone 
analogous to mammalian growth hormone, which could promote growth of 
hypophysectomized fish (Pickford et al., 1957; Lewis et al, 1972). Teleost growth hormone 






(Farmer et al.，1976). Iq the rat tibia assay, 400 ug tilapia growth hormone (tGU) was 
equal in potency to 20 ug bovine growth hormone (bGH) in increasing the tibia width. 
Tilapia growth hormone was found to be approximately equipotent to bovine growth 
hormone (bGH) in promoting growth in two intact teleost species, Oreochromis 
mossambicus (tilapia^  ) and Oncorhynchiis nerka ( sockeye salmon), whereas tilapia 
prolactin (tPRL) was inactive (Clarke et al, 1977). Teleosts could readily distinguish tilapia 
growth hormone and tilapia prolactin although the two hormones are structurally similar. 
Growth hormone binding sites 
I 
I 
• Growth hormone binding sites have been well characterized in mammalian species. 
I 
It is believed that this polypeptide hormone binds to the plasma membranes of the target 
site before carrying out its biological actions. It was first found out by doing whole body 
autoradiographs after injection of ^ ^^I-human growth hormone into a hypophysectomized 
rat (Van Wyk et al., 1974), growth hormone was intensely accumulated in the liver, kidney 
and adrenal. It suggested that liver, kidney and adrenal played a role in metabolizing the 
hormone and removing it from the circulation. Radioreceptor assay had been used to study 
the interaction between growth hormone and receptors on plasma membranes. Lesniack 
et al. (1973) found that specific ^ ^^I-human growth hormone (^^^I-hGH) binding was present 
on cultured human lymphocytes. Specific growth hormone binding sites have also been 
demonstrated in other mammalian species. Rabbit liver membranes possess specific 
h G H binding sites. The ^^^hGH binding to the liver membranes could be inhibited by 
human growth hormone (hGH), bovine growth hormone (bGH) and ovine growth hormone 
1 The tilapia species of Oreochromis mossambicus is previously named as 
Tilapia mossambica and Sarotherodon massambicus. 
5 
(oGH) (Tsushima et al.，1973). Specific ^^^l-hGH binding was also present in various 
I 
tissues of rat, such as the diaphragm, adipose tissue and skeletal muscle, as well as in the 
liver (Posner et al, 1974). High and significant specific binding of ^ ^^I-hGH was found in 
rat and rabbit liver membranes. Since the liver is a particularly abundant source of growth 
hormone receptor, the purification and characterization of hepatic growth hormone 
receptors have been intensively studied. Since h G H has both somatogenic and lactogenic 
activities, ^ ^^I-hGH specifically binds to two different types of receptors on rat liver 
membranes (Postel-Vinay et al., 1976). ^^^I-hGH binds not only to the lactogenic site and 
the binding can be inhibited by prolactin. It can also bind to the somatogenic site which 
cannot bind prolactin. 
125 
I-bGH was also used to demonstrate the presence of specific growth hormone 
binding sites on rat liver membranes. Ranke et al. (1976) found that specific ^^^I-bGH 
binding was present in rat hepatocytes，and the binding was specific for growth hormone. 
Human, rat and bovine G H s could inhibit ^^^I-bGH binding to the G H binding sites 
whereas prolactin did not have such activity. Growth hormone binding sites were also 
found in rabbit liver (Herington and Veith，1977)，bovine liver (Hung and Moore, 1984) and 
mouse liver membranes (Posner, 1976). 
Solubilization of G H binding sites from rabbit liver membranes had been successfully 
done by Herington and Veith (1977). The G H binding sites were solubilized by non-ionic 
detergent Triton X-100, and they showed binding characteristics similar to those of the 
particulate membrane preparation. Purification of G H receptor from rabbit liver 






The purified receptor possessed high affinity for the binding of bovine growth hormone 
and low affinity for ovine prolactin. The molecular weight ( M W ) of the receptor was about 
300 K. One major band and two minor bands were observed in sodium dodecyl sulphate 
(SDS)-polyacrylamide gel electrophoresis. The main band corresponded to a M W of about 
75 K to 80 K，which was expected of the tetrameric subunit of the G H receptor. Tsushima 
(1980) had also purified and characterized hepatic G H receptor from rabbit liver. The GH-
binding site in rabbit liver was successfully solubilized with Triton X-100. Solubilization did 
not cause any major changes in the properties of the GH-binding protein. The apparent 
M W was found to be about 200 K by a Sepharose 6B column. Isoelectric focusing analysis 
of the G H receptor revealed an acidic pi of about 4.5 . Adsorption of the GH-binding 
protein to concanavalin A-Sepharose suggested that it may be a glycoprotein. Affinity 
chromatography using concanavalin A-Sepharose (Con A-Sepharose) was found to be 
effective in the purification of the GH-binding protein. Hepatic growth hormone receptors 
have been isolated and characterized from rabbit and rat but not yet from fish. In the 
present study, a partial purification of tilapia hepatic G H receptor was attempted. 
Mechanism of action of growth hormone 
It is well known that growth hormone can promote growth. Many of the actions of 
growth hormone are mediated by somatomedins, a family of insulin-like peptides. 
Somatomedin is defined as a growth hormone-dependent hormonal peptide which mediates 
the actions of growth hormone. It was first discovered as "sulphation factor"�because it can 
stimulate radioactive sulphate incorporation into cartilage, and it mediates the action of 
growth hormone on various types of cartilage (Salmon and Daiighaday, 1957). Salmon and 
7 
Daughaday found that cartilage from hypophysectomized rats exhibited suppressed uptake 
Q C 
of S-sulphate, and it could be restored within 24 hours after growth hormone treatment 
in vivo. It is important to find that growth hormone or sera from hypophysectomized rats 
had no stimulatory effect on ^^S-sulphate uptake, whereas sera from normal rats or sera 
from hypophysectomized rats which received growth hormone could stimulate ^ ^S-sulphate 
uptake into cartilage in vitro. For this reason, the activity in serum is considered as a 
substance which mediates the action of growth hormone on cartilage growth. 
The term "sulphation factor" is too restrictive in meaning because it was later found 
to stimulate thymidine uptake by cartilage and exert non-suppressible insulin-like activity 
in adipose tissue, in addition to stimulation of ^ S^ uptake by cartilage (Van Wyk et al.， 
1971; Zingg and Froesch, 1973). The originally proposed term "sulphation factor��was 
changed to a hybrid term "somatomedin" which connoted "a hormonal relationship to 
somatotropin (GH) and also to the soma which is the target of this agent. Medin is 
included in the name to indicate that it is an intermediary in somatotropin action" 
(Daughaday et al, 1972). Three somatomedins with different isoelectric point (pi), have 
been purified. The acidic form of the sulphation factor was called somatomedin A. A 
putative neutral glial growth factor was called somatomedin B，and it was later found not 
to be growth-hormone dependent and not to be a true growth factor. A basic sulphation 
factor was called somatomedin C. 
Non-suppressible insulin-like activity (NSILA) was found in serum and could not be 
suppressed with antibodies to insulin (Froesch et al., 1963). Two species of NSILAs in • 
human plasma were isolated. The structures of these 2 different peptides showed 50 % 
8 
homology with proinsiilin (Rinderknecht and Humbel, 1976, 1978a, 1978b). Based on the 
structural and functional similarities to insulin, they are named insulin-like growth factor 
I and II (IGF-I and IGF-II). In 1983，somatomedin C was shown to be completely identical 
to insulin-like growth factor I (Klapper et al, 1983). The terms somatomedin C and 
insulin-like growth factor I are used interchangeably by most researchers. 
Insulin-like growth factor I activity was found in a variety of species. It was detected 
in mammals, such as the rat, guinea pig, hamster, mouse, cat, rabbit, horse, man, fetal calf, 
1 
lamb, pig, goat and newborn calf with a radioreceptor assay using placental membrane and 
radioimmunoassay using ^ ^^I-IGFI，whereas in non-mammalian species, pigeon and chicken 
sera had a very low level of IGF-I-like activity in both radioreceptor assay and 
radioimmunoassay; no IGF-I-like activity in either radioreceptor assay or radioimmunoassay 
was found in sera of turtle, frog, carp, shark and hagfish (Wilson and Hintz, 1982). For 
non-mammalian species, chicken and turtle sera exhibited a very low level of IGF-I-like 
activity in a human IGF binding protein assay but no IGF-I-like activity in either 
radioreceptor assay using rat liver membrane or radioimmunoassay; whereas frog serum did 
not contain IGF-I-like activity in any of the aforementioned assays (Zangger et al” 1987). 
Daughaday et al. (1985) found that non-mammalian species such as chicken, turtle, toad and 
rainbow trout sera contained a very low level of IGF-I-like immunoreactivity; whereas sera 
of chicken and turtle, but not toad and rainbow trout, also contained IGF-II-like activity in 
radioreceptor assay using rat placental membranes. Van den Brande et al. (1974) found 
that turtle but not pigeon and carp (Cyprinus carpio) sera, contained somatomedin activity 
in the human cartilage sulphate uptake assay. Shapiro and Pimstone (1977) found that a 
low level of sulphation factor activity was detected in sera of chicken, duck, tortoise, toad, 
9 
rainbow trout, dogfish and shark in the porcine cartilage sulphate uptake assay. The 




Aim of present research 
Although structure of teleost G H has been elucidated, the biological actions of G H , 
its mechanism of action, G H receptor chemistry and environmental factors affecting growth 
hormone secretion in teleost are not well known. Therefore the intention of the present 
study was to investigate the biological actions of b G H in intact tilapia (since technical 
difficulties were encountered in the hypophysectomy of tilapia and hence intact tilapia were 
used instead), to characterize the GH-binding sites, to characterize the somatomedin C-
like immunoreactivity in tilapia and finally to examine the effects of salinity and diet on 
somatic growth and hormones secretion in tilapia. Hopefully the results from such studies 
would enable one to have a fuller understanding of the phenomenon of growth in tilapia. 
10 
Chapter 2 Metabolic effects of bovine growth hormone in tilapia 
Introduction 
Mammalian growth hormone is strictly responsible for stimulating growth. 
Hyposecretion of growth hormone leads to dwarfism. In the case of hypersecretion of 
growth hormone in young animals, the epiphyses have not yet fused to the long bones, 
stimulation of chondrogenesis and widening of cartilaginous epiphyseal plates occurs leading 
to gigantism. In adults, excessive growth hormone secretion causes the enlargement of the 
bone of face: the clinical condition is known as acromegaly. The growth-promoting activity 
of growth hormone can be measured by the classical rat tibia assay. Briefly, the increase 
in width of the growth plate (epiphyseal plate) of hypophysectomized rats is measured after 
growth hormone administration. 
The biological activities of growth hormones have been extensively investigated, 
although no unified picture has emerged. It can be divided into a protein-anabolic effect 
and effects on carbohydrate and lipid metabolism. The protein-anabolic effect of growth 
hormone involves increase in nitrogen balance, which is due to positive influences on 
protein synthesis in muscle, liver and other organs. Growth hormone increases the 
incorporation of amino acids into proteins and radioactive precursors into R N A (Talwar et 
al” 1962, 1964). The effect of growth hormone on carbohydrate and lipid metabolism can 
be divided into acute insulin-like and chronic anti-insulin-like activities (for review see 
Davidson, 1987). Insulin-like activities 'occur soon after the tissue is exposed to growth 
I 
hormone. The rapid and transient insulin-like effects of growth hormone include increase 
11 
in glucose utilization and anti-lipolysis such as decrease of blood glucose in 
hypophysectomized rats (Hart et al., 1984; Batchelor et al., 1976) and free fatty acid level 
in human after growth hormone treatment (Cheng et al., 1970; Fineberg et al, 1974)，which 
lasts for only approximately an hour. On the other hand, the chronic anti-insulin-like effects 
of growth hormone occurred only after a time lag of several hours after growth hormone 
administration, which includes inhibition of glucose utilization and stimulation of lipolysis. 
Lippe et al. (1981) found that chronic growth hormone treatment increased the fasting 
blood glucose concentration, hepatic glucose production and blood insulin level in growth 
hormone-deficient children. Although insulin secretion was increased, the effect of growth 
hormone had diminished the action of insulin, hence the sensitivity to injected insulin was 
decreased after 3 injections of growth hormone. The lipolytic effect involved increase in 
fasting serum free fatty acid concentration 4 hours after growth hormone administration to 
growth hormone-deficient children (Grunt et al” 1967). It was consistent with the finding 
of fat atrophy at the sites of repeated injections in GH-deficient children (Collipp et al., 
1973). The increase in plasma free fatty acid provides a steady supply of energy for the 
� 
] 
tissues during hypoglycemia, fasting and;stressful stimuli. 
In teleosts, growth hormone has been found to be lipolytic in goldfish (Minick and 
Chavin，1970) and rainbow trout (Leatherland et al, 1981). The increase in plasma free 
fatty acid in growth hormone-treated fish appears to be correlated with a lowering of 
hepatic lipid reserve indicative of lipid mobilization, whereas plasma cholesterol is 
unaffected. Bovine growth hormone can also increase muscle nonesterified fatty acid in 
kokanee salmon (Oncorhvnchus nerka) (McKeown et al, 1975)，and stimulate lipid 
mobilization in coho salmon (Oncorhvnchus kisutch) which includes depletion of total liver 
12 
lipids and elevation of liver lipase activity (Sheridan, 1986). Goodman and Schwartz 
(1974) find that under growth hormone influence, fat is utilized for energy in preference to 
both carbohydrate and protein in rats. Few studies have been conducted to examine the 
effect of growth hormone on amino acid metabolism in fish. Matty (1962) finds no 
significant changes in plasma concentrations of amino nitrogen of Cottus scorpiiis treated 
with mammalian growth hormone. Prack et al. (1980) find that administration of bovine 
growth hormone to goldfish reduces plasma amino acid levels in one of the three 
experiments conducted. However, Inui et al. (1985) find that bovine and ovine growth 
hormones are effective in elevating plasma amino nitrogen levels of both intact or 
hypophysectomized eels after 48 hours. Higgs et al. (1976) have demonstrated that bovine 
I 
growth hormone is capable of increasing the muscle protein content in coho salmon. 
I 
In the present investigation, bovine growth hormone was injected into intact tilapia 
to see if the hormone could exert metabolic effects. Bovine growth hormone was used 
instead of tilapia growth hormone because of the inadequate supply of the latter hormone 
and intact fish were employed due to the lack of expertise in hypophysectomizing tilapia. 
Demonstration of activity of bovine growth hormone in tilapia was a prerequisite to studies 
such as tissue distribution of growth hormone binding sites using iodinated bovine growth 
hormone as ligand. 
13 




Five successive daily intramuscular injections of 25 ug bovine growth hormone (in 
lOOul saline) were given to tilapia (n � 12) weighing about 50 g. The control group 
received saline (0.8 % NaCl) instead. They were fed an artificial diet? (Star Green Mini, 
Yeaster Company Limited, Japan) at a dose of 0.5% of the body weight per day. Twenty-
four hours after the last injection, the fish were sacrificed and blood and liver samples were 
collected. Serum glucose, free amino acid, protein, lipid and cholesterol were measured. 
Liver samples were homogenized in ice-cold phosphate buffered saline, and total protein, 
lipid, glycogen and enzyme activity in the samples were measured as follows. 
Serum glucose determination 
glucose oxidase 
Glucose + 2H2O + O2 〉Gluconic acid + 
peroxidase 
o-Dianisidine + H2O2 > Oxidized o-Dianisidine 
(colorless) (brown) 
Serum glucose level was measured by the glucose oxidase-peroxidase method (Sigma 
Procedure 510). In the coupled reactions, glucose and a colorless dye (o-dianisidine) were 
changed into gluconic acid and an oxidized colored dye (brown o-dianisidine). Briefly, 10 
ul serum was added to 1 ml color-enzyme reagent (containing glucose oxidase, peroxidase 
and o-dianisidine). After incubation at 37°C for 30 minutes, the absorbance of the colored 
2 The artificial diet contained crude protein (38 % minimum), crude fat (4 % 
minimum), crude fibre (3 % maximum), crude ash (12 % maximum), nitrogen free extract 
(33 % minimum) and moisture (10 % maximum). 
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product was measured at 450nm. Different concentration of glucose were used to construct 
the standard curve. 
Serum free amino acid determination 
Serum free amino acids were measured using ninhydrin and hydrazine reagent 
according to the method of Matthews et al. (1964). Twenty ul serum was deproteinized by 
adding 500 ul 10 % trichloroacetic acid (TCA). After centrifugation, 200 ul supernatant 
was added to 1.5 ml ninhydrin-hydrazine sulphate solution (containing 0.447 % ninhydrin, 
0.0087 % hydrazine sulphate, 0.0027 % H2SO4, 1.9 % acetic acid, 33.3 % 2-methoxy ethanol 
and 0.27 M sodium acetate buffer, p H 5.3). The mixture was boiled for 15 minutes and the 
absorbance was measured at 570 nm. Different concentrations of leucine were used to 
construct the standard curve. 
Serum protein determination 
Serum protein was measured by using the method of Lowry et al. (1951) as modified 
by Hartree (1972). Five hundred ul scruni (after 100-fold dilution) was added to 450 ul 
solution A (containing 0.2 % potassium sodium tartrate, 10 % Na^COs and 2 % NaOH). 
The mkture was heated at 50°C for 10 minutes. Fifty ul solution B (containing 0.2 % 
potassium-sodium tartrate, 0.1 % CUSO4.5H2O and 0.04 % N a O H ) was added to the 
mixture. After 10 minutes, 1.5 ml solution C (containing 6.25 % Folin-Ciocalteu reagent) 
was added into the mixture which was tl:jen heated for 10 minutes. The absorbance of the 
I 
blue complex was measured at 650 nm. Different concentrations of bovine serum albumin 
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(BSA) were used to construct the standard curve. 
Serum lipid determination 
Serum total lipid was measured by the sulpho-phospho-vanillin method (Woodman 
and Price, 1972). Twenty ul serum was boiled in 500 ul concentrated H2SO4 for 10 minutes. 
One hundred and fifty ul of the mixture was added to 3.75 ml vanillin reagent (containing 
•2 % vanillin and 80 % H3PO4). After standing for 30 minutes at room temperature, the 
absorbance was measured at 520 nm. Olive oil was used as the standard. 
Serum cholesterol determination 
cholesterol esterase 
Cholesterol esters + H2O2 > Cholesterol 
+ Fatty acids 
cholesterol oxidase 
Cholesterol + O2 > Cholest-4-en-3-one 
+ H2O2 
peroxidase 
4-Aininoantipyrine + H2O2 > Quinoneimine Dye 
+ p-Hydroxybenzenesulfonate + H2O2 
Serum cholesterol was measured by the cholesterol esterase-oxidase-peroxidase 
I 
reaction (Sigma procedure 352). Ten ul serum was added to 1 ml enzyme-color reagent 
I 
(containing cholesterol esterase, cholesterol oxidase, peroxidase, 4-aminoantipyrine and p-
hydroxybenzenesulfonate). After incubation at 37°C for 30 minutes, the absorbance of the 
colored product was measured at 500 nm. Different concentrations of cholesterol were used 
to construct the standard curve. 
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Liver glycogen determination 
Liver glycogen was measured as described by Chung (1978). Free glucose level was 
first determined in the liver homogenate by the glucose oxidase-peroxidase method (Sigma 
Procedure 510). Another aliquot of liver homogenate was incubated with amyloglucosidase 
(20ug liver : 200ug amyloglucosidase in 400ul 0.2M citrate buffer, p H 4). After overnight 
incubation at room temperature, the mixture was centrifuged and the supernatant was used 
to determine total glucose level. The glycogen level was determined by subtracting the free 
I 
glucose level from the total glucose obtained after enzymatic digestion. 
Liver protein determination 
Liver protein was determined as described for serum protein (Hartree, 1972). The 
liver sample was homogenized in ice-cold phosphate buffered saline (1 g liver in 10 ml 
phosphate buffered saline). The homogenate was diluted 50 fold with phosphate buffered 
saline and a 500 ul aliquot was then added to 450 ul solution A (containing 0.2 % 
potassium sodium tartate, 10 % NaCOg and 2 % NaOH). The mixture was heated at 50°C 
for 10 minutes. Fifty ul solution B (containing 0.2 % potassium-sodium tartate, 0.1 % 
CUSO4.5H2O and 0.04 % N a O H ) was added to the mkture. After 10 minutes, 1.5 ml 
solution C (containing 6.25 % Folin-Ciocalteu reagent) was added to the mkture and 
heated for another 10 minutes. The absorbance of the blue complex was measured at 650 
nm. Different concentrations of bovine serum albumin were used to construct the standard 
curve. 
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Liver lipid determination 
Total lipid in the liver homogenate was measured after jipid extraction as described 
for serum lipid (Woodman and Price, 1972). Briefly, the liver homogenate which contained 
20 mg / 200 ul was extracted 3 times by shaking with 1 ml chloroform/ methanol mixture 
(1:3 v/v). After centrifugation at 1000 g, the supernatant was mixed with 1 ml 0.7 % NaCl 
I 
solution and allowed to stand at 4°C for 30 minutes. The top aqueous layer was removed 
and the bottom organic layer was evaporated to dryness. It was then boiled in 0.5 ml 
concentrated U^^O^ for 10 minutes. The mixture (0.1 ml) was transferred to 2.5 ml 
vanillin reagent (containing 0.2 % vanillin and 80 % H3PO4). After standing for 30 
minutds，the absorbance was measured at 520 nm. Different concentrations of cholesterol 
was used to construct the standard curve. 
Measurement of Liver glycogen synthetase activity 
Liver glycogen synthetase activity was measured as described by Sheridan et al. 
(1985). Briefly, the liver homogenate which contained 0.1 g liver in 1 ml phosphate buffer 
saline was centrifuged at 10,000g for 10 minutes. The resulting supernatant was diluted 
1000 fold and an aliquot of 50 ul was incubated with 1 ml reaction mixture (containing 50 
m M Tris-HCl buffer, p H 7.8，10 mg / ml glycogen, 1 m M E D T A , 4 m M cysteine, 3 m M 
uridine diphosphoglucose, 1 m M glucose-6-phosphate) at 23°C for 45 minutes. The reaction 
mkture was then boiled for 30 seconds and cooled in a ice-bath. Twenty ul of a 10 m M 
phosphoenolpyruvate solution (containing 0.4 M KCl and 0.1 M M g C y was added to the 
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mixture which was then incubated at 37°C for 30 minutes. One ml of a 19.8 % 
dinitrophenyl hydrazine solution (in 1 M HCl) was added and the mixture was allowed to 
stand at room temperature for 20 minutes. One ml 4 M N a O H was added and the mbcture 
was allowed to stand for another 10 minutes. The absorbance of the mkture was measured 
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Results 
Changes in levels of amino acid, glucose, protein, lipid and cholesterol in serum, and 
protein，glycogen, lipid and glycogen synthetase activity in liver of tilapia after five 
successive daily intramuscular injections of b G H (50 ug / 100 g each) are summarized in 
Table 1-1. A n anti-insulin response was produced twenty four hours after the last injection 
of b G H , the serum levels of amino acid and glucose were significantly increased. However 
serum concentration of protein, lipid and cholesterol did not show any significant changes. 
Liver glycogen content and liver glycogen synthetase activity was significantly 





Table 1-1 Metabolic Effects of bovine growth hormone (bGH) in tilapia 
b G H treated group Saline treated group 
Serum metabolites 
amino acid (mg/100ml) 78.0 ± 1.9 * 57.6 ± 3.5 
glucose (mg/100ml) 119.6 土 8.4 * 93.6 土 4.4 
protein (mg/ml) 25.2 土 5.2 27.6 土 1.3 
lipid (mg/ml) 7.9 ± 0.8 9.9 ± 0.7 
cholesterol (mg/ml) 1.6 土 0.1 1.8 ±0.1 
Liver metabolites 
protein (mg/g) 124.7 ± 3.7 117.4 土 4.3 
glycogen (mg/g) 66.8 ±10.? “ 109.7 土 7.7 
lipid (mg/g) 47.4 ± 4 j 41.9 土 5.8 
Liver enzyme activity 
glycogen synthetase 
(umol UDP/min/g protein) 1.6 土 0.1 *** 2.4 ±0.1 
Each group consisted of 12 fish each weighing about 50 g. The b G H treated group 
received 50 ug/ 100 g fish /injection for 5 successive daily injections. Serum metabolites, 
liver metabolites and liver enzyme were measured as described in Materials and Methods. 
Values are expressed as means 土 S E M of duplicate determinations. 
P < 0.05, **: p < 0.01 and p < 0.001 by Student's t test. 
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Discussion 
Bovine growth hormone was found to be biologically active in tilapia. It was capable 
of elevating the serum levels of amino acids and glucose, and decreasing liver glycogen 
content and glycogen synthetase activity. These anti-insulin activities of b G H were 
produced after 5 daily injections of bovine growth hormone at a dose of 25 ug/ 50g fish 
/injection. 
In fish, growth hormone was found to be lipolytic. Minick and Chavin (1970) found 
that growth hormone increased the plasma concentration of free fatty acid in the carp 
Carassius aiiratus. It was consistent with the finding of Leatherland et al. (1981) that 
chronic treatment of bovine growth hormone (7 daily injections of 10 ug bGH/g fish 
/injection) significantly elevated both plasma free fatty add level and liver lipid content in 
rainbow trout. The increase in plasma free fatty acid level appeared to be correlated with 
the lowering of hepatic lipid reserve indicative of lipid mobilization. Sheridan (1986) found 
that bovine growth hormone treatment (1.5 ug/g fish) of implanted pellet stimulated lipid 
mobilization in coho salmon parrs. The increase in plasma free fatty acid concentration and 
depletion of liver lipids was consistent with the increase in lipolytic enzyme (triacylglycerol 
lipase) activity. In smolts，bovine growth hormone became ineffective on lipid mobilization. 
Hypophysectomy in smolts, which characteristically possess high liver lipase activity, 
decreased the liver lipase activity and growth hormone replacement restored most of the 
lipase activity as compared to the sham-operated controls. It suggested that growth 
hormone could stimulate lipid mobilization in developing salmon by enhancing lipolysis 
which was responsible for the process of smoltification-associated lipid depletion. These 
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findings were in contrast to results of the present study that chronic treatment of bovine 
growth hormone did not cause significant changes in serum concentrations of total lipid and 
cholesterol and liver lipid content in tilapia. Whether this discrepancy was due to a species 
difference is not clear because McKeown et al. (1975) also noted that chronic treatment of 
kokanee salmon with ovine growth hormone did not bring about significant changes in 
plasma level of free fatty acid and Inui et al. (1985) did not detect any effect of b G H on 
plasma lipid concentration in the eel. 
The elevation of serum amino acid concentration after chronic treatment of bovine 
growth hormone in tilapia was consistent with the finding in the eel Anguilla japonica (Inui 
et al, 1985). Hypophysectomy decreased plasma amino acids levels in the eels. In contrast, 
48 hours after a single injection of b G H (2ug/g fish), plasma amino acids levels of both 
intact and hypophysectomized eels were elevated. 
The protein-anabolic effect of growth hormone was observed in the 
hypophysectomized eel (Inui and Ishioka, 1985). Ovine growth hormone (2ug/g) increased 
^^C-leucine incorporation into proteins of the liver, skeletal muscle and opercular muscle. 
Addition of ovine growth hormone to the medium (5ug/ml medium) also increased 
leucine incorporation into proteins of liver slices. The liver protein content and serum 
protein concentration were not altered after b G H treatment in tilapia. The rate of amino 
acid incorporation into liver and muscle proteins should be measured in future experiment. 
In tilapia b G H stimulated hepatic glycogen depletion and reduced liver glycogen 






synthetase activity led to reduced hepatic glycogen content. The decrease glycogen synthesis 
from glucose and the availability of more gluconeogenic substrates clue to an increase in 
serum amino acid level contributed to the elevated serum glucose level. Results of the 
present study are consistent with those of Matty et al. (1962) who reported the 
hyperglycemic action of mammalian growth hormone in Cottiis scorpius. Normally, fish 
required a high-protein diet (up to more than 40 % protein in diet) for growth and most 
of the dietary proteins are metabolized and utilized as a source of energy. It would be 
expected that the one of the effects of growth hormone was to promote utilization of 
glucose as the main energy source instead of proteins. This protein-sparing effect may be 
the principal action of growth hormone in promoting growth in tilapia. 
The metabolic effect of b G H was demonstrated in intact tilapia in the present study. 
Intact tilapia was used in view of the lack of expertise in hypophysectomizing tilapia. It is 
generally true that intact fish are less sensitive than hypophysectomized fish to treatment 
with pituitary hormone hence the absence of an effect of b G H on some metabolic aspects, 
for instance, lipid metabolism, might be due to the use of intact rather than 
hypophysectomized tilapia. However, it has been shown that the responses of intact and 
hypophysectomized Anguilla japonica to b G H were qualitatively similar (Inui et al., 1985). 
It is perhaps pertinent to note that there may be a species difference in the response to 
mammalian growth hormone. Positive responses in plasma concentration of lipid (Minick 
and Charin, 1970; Mckeown, 1975; Sheridan, 1986), amino acid (Inui et al, 1985) and 
1 
glucose (Matty, 1962) as well as negative finding in the same parameters (Matty, 1962; 
Mckeown, 1975) have been reported. 
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Chapter 3 Growth hormone binding sites in tilapia 
Introduction 
Mammalian liver is the major target site for growth hormone to exert its effect. 
Since there is no biological assay for growth hormone receptor, specific and high affinity 
binding to iodinated growth hormone can be used to identify the receptor. Growth 
hormone binding sites are also found in tissues other than the liver (Hughes et al, 1985; 
Isaksson et al., 1985)，and the effect of growth hormone on cartilage (Isakasson et al” 1982; 
I 
Lindahl et al, 1986) has been demonstrated. 
Studies of growth hormone binding sites in fishes are few in number. Hepatic 
binding sites for bovine growth hormone have been identified in Gillichthvs mirabilis and 
Acipenser transmentanus but not in tilapia (Tarpey and Nicoll, 1985). Highly purified 
tilapia growth hormone (Farmer et al, 1976) binds hepatic growth hormone receptor in 
several fish species (Gillichthvs. Salmo, Qncorhvnchus and tilapia) (Fryer, 1979). The tissue 
distribution of binding sites for bovine growth hormone in tilapia was examined in the 
present study. 
To understand the hepatic action of growth hormone, the kinetic data of ligand-
receptor binding is very useful in studying the intracellular events after receptor binding. 
Since the liver is a particularly abundant source of growth hormone receptors in the 
mammal, the purification and characterization of mammalian hepatic growth hormone 
receptors have been widely studied (Toshio, 1980; Haldosen et al., 1988). Most recent 
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works included the purification and characterization of mammalian growth hormone 
receptor using the detergent solubilization method and affinity-labelling technique. Isolation 
of growth hormone receptors involved affinity column chromatography, using growth 
hormone or concanavalin A covalently coupled to a gel matrix. It is the most effective 
technique for large-scale purification of receptors, whereas ion-exchange chromatography 
can only obtain a marginal increase in purity (Tsushima et al., 1980). The use of an 
organomercurial matrix to adsorb growth hormone receptors provides an alternative method 
to purify receptors (Hughes et al, 1986). | This matrix forms covalent linkages with the free 
J 
sulfhydryl groups of growth hormone receptors. Elution can be done by a competing 
sulfhydryl (eg. 2-mercaptoethanol) with a high recovery of the receptors. The recent 
development of monoclonal antibody to growth hormone receptor provides another means 
of affinity chromatography for purification of the receptor (Simpson et al., 1983). 
Growth hormone receptors have been isolated and characterized from mouse (Smith 
et al, 1987)，rat (Husman et al, 1988，1989) and rabbit (Spencer, 1988) livers but not yet 
from fish liver. Rabbit hepatic growth hormone receptors had been successfully solubilized 
by Herington and Veith (1977). In the present study, tilapia hepatic growth hormone 
receptor was solubilized with a similar technique using Triton-X 100 and was partially 
purified by concanavalin A-Sepharose, DEAE-BioGel A and Sepharose 4B chromatography. 
Its biochemical characteristics were investigated. 
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Materials and Methods 
Preparation of membranes from various organs of tilapia 
Preparation of tilapia liver membranes, as well as kidney, muscle, intestine, stomach, 
gill filament and heart membranes, was based on the original method for pregnant rabbit 
liver membranes (Tsushima & Friesen，1973) modified by Herington et al. (1976 a, b). All 
steps were performed at ice-cold temperature. Tilapia tissue (collected from 30 fish) was 
rinsed in 0.3M sucrose, blotted dry and weighed. The tissue was minced and homogenized 
in about 4 volumes of 0.3M sucrose solution. The homogenate was centrifuged at 10,000 
g for 10 minutes and the resulting supernatant was ultracentrifuged at 105,000 g for 60 
minutes. The supernatant from the ultracentrifugation step was discarded and the pellet 
was rehomogenized in 25 m M Tris-HCl buffer (pH 7.2). The protein concentration of the 
membrane preparation was determined by the method of Lowry et al. (1951). The 
membrane preparation was stored at -70〇C until it was used for binding studies. 
Radioiodination of growth hormone 
The iodination of tGH and b G H was done at room temperature by the 
lactoperoxidase method (Thorell & Johansson, 1971; Li et al., 1981). For iodination, 5 ug 
growth hormone (gift from Li, CH.) was added to 1 mCi (10 ul) (Amersham), 20 ul 
0.4 M sodium acetate buffer (pH 5.6) and 5 ug lactoperoxidase in 10 ul acetate buffer 
(Calbiochem). To initiate the iodination, 150 ug H2O2 (10 ul) was added with constant 
I 
flicking. After 1 minute, the reaction was stopped by addition of 100 ul transfer buffer 
I 
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(0.0IM sodium phosphate, 1 % KI，16 % sucrose, 0.1 % sodium azide, p H 7.5)，followed 
by 50 ul of 5 % BSA. An aliquot of 10 ul was used to determine total and specific 
activities. The ^^^I-GH was separated from free by gel filtration on a 1 x 50 cm 
Sephadex G-lOO (Pharmacia) column using an eluting buffer containing O.OIM sodium 
phosphate and 0.15 M sodium chloride (pH 7.6). 
The specific radioactivity of the labelled hormone was determined as described by 
Shiu & Friesen (1974). Ten ul was taken from the stopped iodination mixture and diluted 
50,000 fold with 25 m M Tris-HCl buffer (pH 7.2) containing 0.5 % BSA. One ml of the 
diluted mixture was added to 2 ml (10 % ) trichloroacetic acid (TCA), mixed and allowed 
to stand at 4°C for 1 hour before centrifugation at 2000 g for 20 minutes. The supernatant 
which contained free was then discarded. The radioactivity incorporated into the 
hormone was obtained by counting the pellet. From the amounts of hormone and used, 
the specific radioactivity of the labelled hormone could be calculated. O n the other hand, 
this specific activity could be estimated from the total radioactivity incorporated into the 
iodinated growth hormone peak but with less accuracy. 
Radioreceptor assay using ^ ^^I-GH as ligand 
When the particulate membrane receptor was used, the ^^^I-bGH and ^^^I-tGH 
binding studies were done in triplicate by the method described by Shiu & Friesen (1974) 
as modified by Herington et al. (1976c)., Membrane preparation containing Img protein 
i 
(unless otherwise stated) in 100 ul assay buffer (25 m M Tris-HCl buffer, p H 7.2，containing 
20 m M CaCl2 and 0.4 % BSA) was incubated with 100,000 cpm ^^^l-GH (100 ul) with or 
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without uiilabelled G H in a final volume of 500 ul for 16 hours at room temperature 
(20°C). The binding reaction was terminated by dilution with 3 ml ice-cold 25 inM Tris-
HCl buffer (pH 7.2) containing 20 m M CaCl^ and 0.4 % BSA. Separation of the free and 
bound hormone was achieved by centrifugation at 5,000 g for 60 minutes. The supernatant 
was decanted and the ^ ^^I-GH bound to the membrane pellet was counted in a Beckman 
gamma counter. 
When the solubilized membrane receptor was used, the ^^^I-tGH binding studies 
were done in triplicate by the method described by Herington and Veith (1977). The 
solubilized receptor preparation containing 300 ug protein (unless otherwise stated) in 100 
I 
ul assay buffer (25 m M Tris-HCl buffer, p H 7.2，containing 10 m M CaCl? and 0.4 % BSA) 
I 
was incubated with 100,000 cpm ^ ^^I-tGH (100 ul) with or without unlabelled tGH in a final 
volume of 500 ul for 16 hours at room temperature (20°C). The final concentration of 
Triton X-100 in the final volume of 500 ul was 0.1 % . The binding reaction was terminated 
by dilution with 0.5 ml of ice-cold 0.1 M NaHsPO* (pH 7.5) followed by 1 ml of ice-cold 
25 % (w/v) polyethylene glycol (PEG 6000). The solution was mixed and allowed to stand 
for 60 minutes at 4°C. Separation of the free and bound hormone was achieved by 
centrifugation at 5,000 g for 60 minutes. The supernatant was decanted and the ^ ^^I-tGH 
bound to the pellet was counted in a Beckman gamma counter. 
The inclusion of calcium has been reported to increase the binding of hormone and 
to allow complete sedimentation of the membrane during centrifugation of the hormone-
membrane complex (Tsushima & Friesen, 1973; Posner et al, 1974). B S A was used to 
minimize non-specific adsorption of hormone to the test-tube and a sufficient amount of 
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1251-GH was added in order to increase the accuracy of the binding system (Brooks et al., 
1982). 
Total binding was measured in the absence of uniabelled hormone and non-specific 
binding was obtained by measuring the amount of ^ ^^I-GH bound in the presence of 1 ug 
of the uniabelled growth hormone. Specific binding was obtained by simply subtracting the 
non-specific binding from the total binding. 




Solubilization of hepatic growth hormone receptors was done by the method 
described by Herington and Veith (1977). Tilapia liver membrane preparation (obtained 
as described previously) was suspended in buffer (10 mg protein in 1 ml 25 m M Tris-HCl 
buffer, p H 7.4，containing 10 m M CaCl?，0.1 % B S A and 1 % Triton X-100). The mixture 
was stirred for 30 minutes at 20°C before ultracentrifugation at 125,000 g for 3 hours. The 
supernatant (solubilized liver membrane protein) was stored frozen at -70°C and the protein 
concentration was determined by the Bradford Coomassie Brilliant Blue G-250 method 
(Bradford, 1976)，using B S A as standard. Briefly, solubilized liver membrane protein was 
diluted 40 fold, an aliquot of 0.1 ml was added to 1 ml Bradford reagent (containing 0.01 
% (w/v) Coomassie Brilliant Blue G-250, 8.5 % (w/v) phosphoric acid, 4.7 % (w/v) 
ethanol), mixed and allowed to stand at room temperature for 10 minutes. The absorbance 






Partial purification of tilapia hepatic G H receptor 
Tilapia hepatic growth hormone receptors were partially purified by using affinity 
chromatography on Concanavalin A-Sepharose (Pharmacia), ion-exchange chromatography 
on DEAE-BioGel A (Bio-Rad) and gel filtration on Sepharose 4B (Pharmacia). In all 
chromatographic procedures, the elution buffer contained 0.1 % Triton X-100 to prevent 
precipitation of the solubilized receptors. 
The molecular weight of tilapia solubilized hepatic G H receptor was initally 
determined by gel filtration on a Sepharose 4B column in 25 m M Tris-HCl buffer 
(containing 0.1 % Triton X-100, p H 7.2). Briefly，7 mg crude solubilized tilapia liver 
membrane proteins were applied to the column in 1 ml. The effluent was monitored by 
U V absorbance at 280 n m and G H receptor binding assay. 
The Con A-Sepharose column (10 cm x 1.6 cm) was washed with 2 5 m M Tris-HCl 
buffer (containing 1 m M CaCl?，1 m M MgCl?，0.5 M NaCl and 0.1 % Triton X-100, p H 7.2) 
and then equilibrated with 25 m M Tris-HCl buffer (containing 0.1 % Triton X-100, p H 7.2) 
before the application of solubilized liver membrane proteins. After application of the 
sample, the column effluent was monitored by U V absorbance at 280 nm. After the 
unadsorbed peak (Con A I) had been eluted from the column, the adsorbed peak 
containing glycoproteins (Con A II) was eluted by 25 m M Tris-HCl buffer (containing 0.3 
M a-methyl-D-mannoside and 0.1 % Triton X-100, p H 7.2). The collected fractions were 
concentrated by ultrafiltration using a membrane with a M W cut-off of 10,000 (Spectra) and 
the mannoside was removed by gel filtration on Sephadex G-50 (Pharmacia) in 25 m M Tris-
HCl buffer (containing 0.1 % Triton X-100, p H 7.2). 
1 
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The DEAE-BioGel A column was used to further fractionate the Con A II fraction 
of solubilized liver membrane proteins. The column was first equilibrated with 25 m M Tris-
HCl buffer (containing 0.1 % Triton X-100, p H 7.2) before the application of the Con A 
II fraction. After application of the sample, the column effluent was monitored by U V 
absorbance at 280 nm. After the unadsorbed peak (DEAE I) had been washed out, the 
adsorbed material (DEAE II) was eluted by 25 m M Tris-HCl buffer (containing 2.5 M 
NaCl，0.1 % Triton X-100, p H 7.2). The collected fractions were concentrated by 
ultrafiltration using a membrane with a M W cut-off of 10,000 and NaCl was removed by 
dialysis. 
A Sepharose 4B column was used to further fractionate the D E A E II fraction of 
solubilized liver membrane proteins. The column was first equilibrated with 25 m M Tris-
HCl buffer (containing 0.1 % Triton X-100, p H 7.2) and calibrated by molecular weight 
standards. After application of the sample, 1-ml fractions were collected and the 
absorbance of column effluent was monitored by U V absorbance at 280 nm. T h e 
fractions from the various chromatographic steps were tested in the radioreceptor assay 
using i25l-tilapia G H as ligand. 
Sodium dodecyl sulphate (SDS)-polyacrvlamide gel electrophoresis 
The partially purified preparation of tilapia liver G H receptor was studied by 
electrophoresis in 5 % polyacrylamide (BioRad) slab gel in the presence of 0.1 % (w/v) 






method of Laemmli (1970). All the samples for electrophoresis were boiled at 100°C in the 
presence of B-mercaptoethanol for 5 minutes and then stacked in 5 % gel, 0.125 M Tris-
HCl，pH 6.8 and separated in 0.375 M Tris-HCl, p H 8.8. After electrophoresis, the gel was 
placed in fking solution (10 % glutaraldehyde and 15 % acetic acid) for 30 minutes. It was 
then rinsed in distilled water and washed overnight. The gel was then stained for protein 
according to the silver staining method of Oakley et al. (1980). The gel was placed in the 
staining solution (0.42 % ammonium solution, 0.076 % N a O H and 0.8 % AgNOg) for 1 
minute and then in a fresh staining solution for 15 minutes with gentle shaking. The gel 
was washed with distilled water for 2 minutes and then placed in the developing solution 
(0.005 % citric acid and 0.019 % formaldehyde) until a dark background began to develop. 
Finally，the gel was washed in distilled water for 1 hour. If necessary, it was washed in the 
destaining solution (25 % solution of Kodak Rapid Fixer A) to lighten the background, 
followed immediately by immersion in the destainer stopping solution (25 % solution of 





Radioiodination of b G H and tGH 
The iodination profile of ^ ^^I-bGH and ^ ^^1-tGH were shown in Fig. 3.1 and Fig. 3.2， 
respectively. Generally two distinct peaks were observed. The first peak contained 
G H and the second peak contained free Damaged or aggregated hormone was eluted 
in the front of the ^ ^^I-GH, which appeared as a shoulder of the first peak. The ^^^I-GH 
was stored at -20°C in aliquots. The specific radioactivity of labelled growth hormone 
obtained by the lactoperoxidase method was about 100-120 uCi/ug G H . 




Table 3-1 shows the specific and non-specific binding of ^^^I-bGH to tissue 
membranes of male and female tilapia. One thousand ug membrane protein was used 
except for the gill filaments, muscle, anterior gut, posterior gut and spleen because the 
membrane protein concentrations in these cases were less than Img /lOOul. Among the 
tissues examined, liver membranes showed the highest degree of specific binding (around 
3.5 % ) and this was true in both sexes although nonspecific binding was high (5-10 %). The 
low levels (below 1 % ) of specific binding were found in membranes prepared from other 
organs/ tissues, again associated with extensive nonspecific binding. 
Effect of membrane protein concentration on ^^^I-bGH binding to tilapia liver 
membranes was shown in Fig. 3.5. As the membrane protein concentration increased, the 
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bindina of ^ ^^l-bGH to liver membranes increased. The specific binding increased linearly 
I 
whereas the non-specific binding increased but with a decreasing slope. 
I 
Specificity of ^ ^^I-bGH binding to tilapia liver membranes 
The specificity of ^^^I-bGH binding to tilapia liver membranes (Fig. 3.6) was 
characterized by using a constant amount of ^ ^^I-bGH and increasing amounts of bovine 
growth hormone(bGH), ovine prolactin (oPRL), tilapia growth hormone (tGH) or tilapia 
prolactin (tPRL). Addition of increasing amounts of unlabelled b G H resulted in a gradual 
decrease in binding of ^ ^^I-bGH to tilapia liver membranes, with 50 % displacement at 
approximately 30 ng unlabelled b G H . oPRL also competed with ^ ^^I-bGH for binding to 
the liver membranes with a similar potency as compared with bGH: 50 % displacement 
was observed at about 30 ng oPRL. tGH showed a similar displacement curve but with a 
slightly lower potency, with 50 % displacement at about 65 ng tGH. tPRL was not potent 
in inhibiting ^ ^^I-bGH binding even at concentration up to 400 ng per tube. Thus b G H , 
tGH and oPRL were potent inhibitors of ^^^I-bGH binding to tilapia liver membranes 
whereas tPRL was a poor inhibitor. To compare the potency of b G H in inhibiting 
b G H binding to tilapia liver membranes and to rat liver membranes, a displacement curve 
of i25i_bGH binding to rat liver membranes was done (Fig. 3.3). Fifty percent displacement 
was observed at a much lower level of about 7 ng b G H , whereas oPRL was only slightly 
potent with 40 % displacement at about 100 ng oPRL. Scatchard analysis (Fig 3.7) of the 
data of i25i_bGH binding to tilapia liver membranes showed that the maximum binding 
(Bmax) was 180 fmole/mg protein and dissociation constant (Kd) was 13 nM, whereas the 
125 
I-bGH binding sites in rat liver membranes had a Bmax value of 600 fmole/mg protein 
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and a Kd value of 2.5 n M (Fig 3.4). 
Characteristics of ^ ^^I-tGH binding to tilapia liver membranes and solubilized tilapia hepatic 
membrane proteins 
The specificity of ^ ^^I-tGH binding to tilapia liver membranes was characterized by 
using a constant amount of ^ ^^I-tGH and increasing amounts of tGH, b G H , oPRL and tPRL 
(Fig. 3.8). Addition of increasing amounts of unlabelled tGH resulted in a gradual 
decrease in binding of ^ ^^I-tGH. Fifty percent displacement was observed at approximately 
15 ng of unlabelled tGH. b G H also inhibited ^^^I-tGH binding but with a much lower 
potency as compared with tGH, with 50 % displacement at about 110 ng b G H . oPRL was 
only slightly potent, with 40 % displacement at 1000 ng oPRL. tPRL was almost unable 
to inhibit binding of ^ ^^I-tGH, with 10 % displacement at 1000 ng tPRL. tGH, and to a 
lesser extent b G H , were potent inhibitors of ^ ^^I-tGH binding to tilapia liver membranes, 
whereas oPRL and tPRL were poor inhibitors. 
In the case of solubilized tilapia hepatic membrane proteins, a similar specificity of 
i25l-tGH binding was found (Fig. 3.11). Fifty percent displacement of ^ ^^I-tGH binding was 
observed at about 20 ng unlabelled tGH. Mammalian G H and P R L and tilapia P R L were 
not potent in inhibiting ^ ^^I-tGH binding, with 50 % displacement by about 1000 ng bGH, 
40 % displacement by about 1000 ng tPRL and only 30 % displacement by 1000 ng oPRL. 
The specific binding of ^ ^^I-tGH to tilapia liver membranes (300 ug protein) was 9.8 
% of the added radioactivity, which was much higher than the binding obtained when 
丨 3 6 
b G H was used as the ligand, the specific binding was about 3.5 % , whereas the non-specific 
binding was 12.6 % of the added radioactivity. Scatchard analysis suggested a single class 
of i25i_tGH binding sites on tilapia liver membranes. The apparent dissociation constant 
(Kd) and the maximum binding (Bmax) were 2.5 n M and 390 fmole/mg protein respectively 
(Fig. 3.9). 
For the solubilized tilapia hepatic G H receptor, increase in solubilized membrane 
protein concentration caused both the specific as well as non-specific binding of ^ ^^I-tGH 
to increase (Fig. 3.10). However, both specific and non-specific binding was saturable. 
Solubilized tilapia liver membrane protein (300 ug) showed 4 % specific ^ ^^I-tGH binding. 
Scatchard analysis suggested a single class of ^ ^^I-tGH binding sites on solubilized tilapia 
liver membranes. The apparent Kd was 3.9 n M and the Bmax was 360 fmole/mg proteins 
(Fig. 3.12). 
Effect of enzymes on tilapia hepatic G H binding sites 
I 
I 
Table 3-II showed that treatment of tilapia liver membranes with enzymes that 
disrupt the structure of membrane proteins caused a marked decrease in specific binding. 
Trypsin reduced the specific binding from 7.23 % to 4.1 % , and chymotrypsin caused a 
much greater reduction of specific binding to 1.34 % . Ribonuclease, deoxyribonuclease and 
neuraminidase lacked any significant effect on ^^^I-tGH binding. 
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Effect of p-chloromercuribenzene sulfonate (PCMBS) on tilapia hepatic GH-binding sites 
Fig. 3.13 showed that pretreatment of tilapia liver membranes with the thiol group-
reactive reagent P C M B S caused a marked reduction in ^ ^^I-tGH binding. P C M B S produced 
a dose-dependent inhibition with 50 % inhibition of ^ ^^I-tGH binding at about 0.9 m M 
PCMBS. Complete inhibition was achieved at about 4 m M or above. The inhibition of 
i25l-tGH binding by 1 m M P C M B S could be reversed by 5 m M dithioerythritol (DTE) (Fig. 
3.14). 
Partial purification of tilapia hepatic G H receptors 
i 
From a preliminary experiment, the solubilized tilapia liver membranes was 
I 
fractionated on a Sepharose 4B column (Fig. 3.15) and the molecular weight of the 
solubilized tilapia hepatic growth hormone-binding site was about 400,000 (Fig. 3.16). This 
GH-binding site was adsorbed on a Con A-Sepharose column (Fig. 3.17) hence it was first 
purified by affinity chromatography on a Con A-Sepharose. 
In the isolation of tilapia growth hormone receptors (Table 3-III), 350 mg protein 
of tilapia liver membranes were prepared from 23 g (wet weight) of fresh tilapia livers and 
they were solubilized into 263 mg membrane protein by Triton X-100. The profile of 
elution of solubilized tilapia hepatic membrane proteins from a Con A-Sepharose column 
is shown in Fig. 3.18. The unadsorbed Con A I fraction was concentrated by ultrafiltration. 
The adsorbed Con A II fraction was eluted by 0.3 M a-methyl-D-mannoside and similarly 
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concentrated by ultrafiltration. In the radioreceptor assay using ^ ^^1-tGH as ligand, 200 ug 
I 
Con A II fraction exhibited 0.7 % (about 0.013ng tGH) specific binding whereas Con A I 
fraction did not show any binding activity. 
The Con A II fraction was subjected to further purification on a DEAE-BioGel A 
column. The unadsorbed proteins were eluted by 25 m M Tris-HCl buffer (pH 7.2) in the 
D E A E I fraction. The adsorbed proteins were eluted by 2.5 M NaCl (in 25 m M Tris-HCl 
buffer, p H 7.2) in the D E A E II fraction (Fig. 3.19). The D E A E I fraction did not bind 
i25l-tGH whereas the D E A E II fraction showed 2.1 % specific binding when 200 ug protein 
was used. 
The D E A E II fraction was further purified by gel filtration on a Sepharose 4B 
column (Fig. 3.20). Since specific ^^^I-tGH binding was detected in fractions with a 
molecular weight between 350,000 and 600,000, these fractions were pooled and 
concentrated by ultrafiltration. The resulting material showed 0.7 % specific binding when 
15 ug protein was used. The present scheme of isolation of hepatic G H receptor led to a 
3-fold increase in specific activity but only 0.347 % recovery of specific GH-binding activity 
and 0.114 % recovery of protein. 
Fig. 3.21 showed the result of SDS-polyacrylamide gel electrophoresis of the above 
chromatographic fractions. In 5 % gel solubilized tilapia hepatic membrane proteins 
showed many bands throughout the length of the gel. There were many low molecular 
weight as well as high molecular weight bands. The molecular weight of the bands could 










3.22). Fraction Con A II was also heterogenous but a band at about M W 110,000, 2 close 
*bands at about M W 85,000 and several bands at about M W 55,000 were more intense. 
Fraction Con A II-DEAE II had a similar pattern to Con A II because the other bands 
were also present but less intense than Con A II. Fraction Con A II-DEAE Il-Sepharose 
4B was also heterogenous but a distinct and intense band was observed at M W 97,000. 
Several high M W bands were also present although with a low intensity. A stepwise 
increase of purity was observed after Con A-Sepharose and DEAE-Biogel A column 
chromatography. Con A-Sepharose removed most of the impurity from the crude 
solubilized tGH receptors. D E A E Biogel A column caused a marginal increase in the 
purity of the receptor. A final step of purification was achieved by gel filtration on 
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Fig. 3.1 Iodination profile of bovine growth hormone (bGH). 
One ml fractions were collected from a Sephadex G-lOO column (50 x 1 cm) which 
was eluted with 10 m M sodium phosphate and 0.15 M sodium chloride, (pH 7.6). The 
I 
b G H in fractions 20 to 22 was aliquoted 'and stored at -20°C until use for the radioreceptor 
I 
assay. Fractions 26 to 30 represent the free peak. 
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Fig. 3.2 lodination profile of tilapia growth hormone. 
One ml fractions were collected from a Sephadex G-lOO column (50 x 1 cm) which 
was eluted with 10 m M sodium phosphate and 0.15 M sodium chloride, (pH 7.6). The 
tGH in fractions 19 to 22 was aliquoted and stored at -20°C until use for the radioreceptor 
assay. Fractions 29 to 34 represent the free peak. 
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Table 3-1 Binding of ^ ^^I-bGH to tilapia tissue membranes. 
Organ / Membrane Male Female 
tissue protein Specific Non-specific Specific Non-specific 
per tube binding binding binding binding 
(ug) (%) (%) (%) (%) 
Testis 1000 aS^ZtO.lG 3.84±0.06 - -
Ovary 1000 - - 0.60 ±0.08 3.03 ±0.06 
Gill 850 * 0.58±0.18 3.09±0.01 0.27±0.21 4.09±0.13 
filament 
Muscle 470 * 0.11 ±0.13 1.78 ±0.28 0.09 ±0.15 1.52 ±0.02 
Gas bladder 1000 0.09±0.25 4.42±0.01 0.15±0.32 4.55±0.13 
Anterior gut 350 * 0.27±0.33 1,70±0.01 0.65±0.35 0.99±0.09 
Posterior gut 400 * 0.56±0.11 1.52±0.02 0.55±0.26 3.76±0.03 
Spleen 670 * 0.40±0.24 ？.61±0.18 0.76±0.08 2.86±0.19 
1 
Kidney 1000 0.71 ±0.04 4.2：2±0.04 0.81 ±0.17 4.61 ±0.22 
Liver 1000 3.56±0.11 10.7±0.08 3.45±0.10 5.68±0.14 
Stomach 1000 0.99 ±0.29 7.50 ±0.05 0.76 ±0.13 7.38 ±0.05 
Heart 1000 0.43±0.18 3.04±0.14 0.18±0.25 3.83±0.17 
The specific and non-specific binding of ^^^I-bGH (expressed as % of the total 
radioactivity of ^ ^^1-bGH added per tube) to tilapia tissue membranes was determined as 
described in Materials and Methods. Less than 1000 ug protein was used in samples 
marked with asterisks (*) because of the lower protein concentrations of the membrane 
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Fig. 3.3 Specificity of binding of ^ ^^I-bGH to rat liver membranes. 
Inhibition of ^ ^^I-bGH binding by increasing amount of unlabelled b G H and oPRL. 
One hundred percent specific binding represents binding of 11.2 % of the radioactivity of 
i25l-bGH added in the absence of any unlabelled hormone when 300 ug membrane proteins 
was used. Non-specific binding was estimated as 1.7 % of the radioactivity of ^ ^^I-bGH 
added in the presence of lOOOng unlabelled b G H . Values represent means 土 S E M of 
triplicate determinations. S E M is not shown in case it is smaller than 1 % . 
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Fig. 3.4 Scatchard plot of the binding of ^ ^^I-bGH to rat liver membranes. 
Specific binding in Fig. 3.3 was used for Scatchard analysis. The Kd and Bmax were 
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Fig. 3.5 Effect of membrane protein concentration on binding of ^ ^^I-bGH to tilapia liver 
membranes. 
Specific (SB) and non-specific binding (NSB) was determined as described in 
Materials and Methods. Values shown are the means 土 S E M of triplicate determinations 
and expressed as the % of the radioactivity of ^ ^^I-bGH added. S E M is not shown in case 
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Fig. 3.6 Specificity of binding of ^ ^^I-bGH to tilapia liver membranes. 
Inhibition of ^ ^^I-bGH binding by increasing amounts of unlabelled bGH, tGH, tPRL 
and oPRL. One hundred percent specific binding represents binding of 3.9 % of 
radioactivity of ^ ^^I-bGH added in the absence of any unlabelled hormone when 1000 ug 
membrane proteins was used. Non-specific binding was estimated as 10 % of the 
radioactivity of ^^^I-bGH added 
in the presence of 1000 ng unlabelled bGH. Values 
represent means of triplicate determinations. S E M is not shown in case it is smaller than 
1 %. 
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Fig. 3.7 Scatchard plot of the binding of ^ ^^I-bGH to tilapia liver membranes. 
Specific binding in Fig. 3.6 was used for Scatchard analysis. The Kd and Bmax were 
13 n M and 180 fmol/mg protein, respectively. 
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Fig. 3.8 Specificity of binding of ^ ^^I-tGH to tilapia liver membranes. 
Inhibition of ^^^I-tGH binding by increasing amounts of unlabelled tGH, tPRL, oPRL 
and b G H . One hundred percent specific binding represents binding of 9.5 % of 
radioactivity of ^ ^^I-tGH added in the absence of any unlabelled hormone when 300 ug 
membrane protein was used. Non-specific binding was estimated as 12.1 % of the 
radioactivity of ^^^I-tGH added 
in the presence of 1000 ng unlabelled tGH. Values 
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Fig. 3.9 Scatchard plot of the binding of ^ ^^I-tGH to tilapia liver membranes. 
Specific binding in Fig. 3.8 was used for Scatchard analysis. The Kd and Bmax were 
2.5 n M and 390 fmol/mg protein, respectively. 
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Fig. 3.10 Effect of solubilized membrane protein concentration on binding of ^ ^^1-tGH 
to solubilized tilapia liver membrane proteins. 
Specific (SB) and non-specific binding (NSB) was determined as described in 
Materials and Methods. Values shown represent the means of triplicate determinations and 
expressed as % of the radioactivity of ^ ^^I-tGH added. S E M is not shown in case it is 
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Fig. 3.11 Specificity of binding of ^ ^^I-tGH to 
solubilized tilapia liver membrane proteins. 
Inhibition of ^ ^^I-tGH binding by increasing amounts of uniabelled tGH, b G H , tPRL 
and oPRL. One hundred percent specific binding represents binding of 4 % of radioactivity 
of i25i_tGH added in the absence of any uniabelled hormone when 300 ug solubilized liver 
membrane proteins was used. Non-specific binding was estimated as 9 % of the 
radioactivity of ^^^I-tGH added in the presence of 1000 ng uniabelled tGH. Values 
represent means ± S E M of triplicate determinations. S E M is not shown in case it is 
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Fig. 3.12 Scatchard plot of the binding of ^ ^^I-tGH to solubilized tilapia liver membrane 
proteins. 
Specific binding in Fig. 3.11 was used for Scatchard analysis. The Kd and Bmax 
were 3.9 n M and 360 fmol/mg protein, respectively. 
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Table 3-11 Effect of enzyme treatments on binding of ^ ^^I-tGH to tilapia liver membranes 
Expt. Enzyme treatment specific ^ ^^ I-tGFI binding (%) 
1 Control 7.60 土 0.36 
RNase 6.66 土 0.40 
DNase 6.50 土 0.35 
Neuraminidase 8.10 土 0.29 
2 Control 7.23 土 0.35 
Trypsin 4.10 ± 0.17 * 
Chymotrypsin 1.34 ± 0.16 * 
Two milligrams of tilapia liver membranes were incubated at 25°C in the presence 
of enzyme (200 ug / ml) for 1 hour in 25 m M Tris-HCl buffer (pH 7.2) containing 20 m M 
CaQg. At the end of incubation, 1 ml ice-cold buffer was added. The resulting mixture 
was centrifuged at 5000 g for 30 minutes at 4°C. The pellet was washed 3 times before 
resuspension in the assay buffer. Control experiment was performed in the absence of 
enzyme. For treatment with trypsin and chymotrypsin (experiment 2), 13 ug trypsin 
inhibitor and 15 ug aprotinin were added to the membranes after the treatment to inhibit 
the enzyme activity. The corresponding control also received trypsin inhibitor and 
aprotonin. Specific ^^^I-tGH binding was determined as described in Materials and 
I 
Methods. Values shown represent the means of triplicate determinations and expressed as 
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Fig. 3.13 Concentration dependence of p-chloromercuribenzene sulfonate (PCMBS) 
inhibition of ^ ^^I-oPRL binding to tilapia liver membranes. 
The membrane preparation (5 mg protein) was pretreated with various 
concentrations of P C M B S (up to 4 m M ) in a final volume of 3 ml in 25 m M Tris-HCl (pH 
7.2) containing 20 m M CaCl^ at O^C for 1 hour. The incubation mixture was then diluted 
with buffer to 10 ml, and centrifuged at 35,000 g for 20 minutes. The resulting pellet was 
then washed 3 times before resuspension in 25 m M Tris-HCl buffer (pH 7.2) containing 20 
m M CaCl。，to a concentration of 3 mg / ml. The control was carried out in the absence 
of PCMBS. Specific ^ ^^I-tGH binding was measured using 300 ug membrane protein as 
described in Materials and Methods. Values shown represent means of triplicate 
determinations and expressed as % of control (the specific binding of control was 8.6 % of 
the radioactivity of ^ ^^I-tGH added). S E M is not shown in case it is smaller than 1 % . 
55 
* I 
T ？ i 
8 層 - 1 ® 
0 . / 1 丄 ^ / 
90 - / 
g T 
B / 丄 
1 / I 
约 H 70 - / : 
^o I 
v-t / ' 
O ' I 
CD 60 9 ‘ 1 1 I I I . I , 
C^ 0 ’ 5 10 15 20 25 
DTE concentration (mM) 
Fig. 3.14 Reversal of P C M B S inhibition of ^ ^^I-tGH binding to tilapia liver membrane 
by dithioerythritol (DTE). 
The membrane preparation (5 mg protein) was pretreated with 1 m M P C M B S at 0。C 
for 1 hour. It was then treated with different concentrations of D T E (up to 20 m M ) for 1 
hour in final volume of 1 ml in 25 m M Tris-HCl buffer containing 20 m M CaCl? (pH 7.2) 
at 0°C. The incubation mixture was then diluted with buffer to 10 ml and centrifuged at 
35,000 g for 20 minutes. The resulting pellet was then washed 3 times before resuspension 
in 25 m M Tris-HCl buffer containing 20 m M CaCl。(pH 7.2) to a concentration of 3 mg 
/ ml. The control was carried out in the absence of both P C M B S and D T E . Specific 
tGH binding was measured using 300 ug membrane protein as described in Materials and 
Methods. Values shown are the means of triplicate determinations and expressed as % of 
control (the specific binding of control was 8.6 % of the radioactivity of ^ ^^I-tGH added). 
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Table 3-III Isolation of tilapia growth hormone receptors 
Fraction Total Yield Specific Recovery of Purification 
i25l-tGH i25i_tGH activity protein 
binding binding 
activity activity 
(ng tGH) (mg protein) (ng tGH/mg (%) (%) (fold) 
protein) 
solubilized 
membrane 32.0 263 0.122 100 100 1 
proteins 
Con AII 0.681 10.1 0.067 2.13 3.84 0.55 
Con A II-
D E A E II 0.494 5.9 0.083 1.54 2.24 0.68 
Con A II-
D E A E II-
Sepharose 4B 0.111 0.3 0.370 0.34 0.11 3.03 
I 
350 mg liver membranes were prepared from 23 g liver tissue, and then solubilized 
I 
into 263 mg proteins. Total ^ ^^I-tGH binding activity was calculated by dividing the amount 
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Fig. 3.15 Gel filtration of 7 mg solubilized tilapia liver membrane proteins on a 
Sepharose 4B column. 
Column dimensions : 100 x 1 cm. Flow rate : 7 ml / hr. Fraction size : 1 ml. 
Buffer : 25 m M Tris-HCl, p H 7.2, containing 0.1 % Triton X-100. The column effluent was 
monitored by absorbance at 280 nm and G H radioreceptor assay. The receptor binding 
activity was expressed in term of % of radioactivity of ^ ^^I-tGH added. The size of aliquot 
of column fractions used for radioreceptor assay was 200 ul. Thyroglobulin (TG) ( M W 
669,000), apoferritin (Apo) ( M W 443,000), B-amylase (B-Amy) ( M W 200,000), ovalbumin 
(Oval) ( M W 45,000) and carbonic anhydrase (CA) ( M W 29,000) were used as molecular 
weight standards. 
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Fig. 3.16 Molecular weight determination of solubilized tilapia hepatic G H receptor by 
gel filtration on Sepharose 4B. 
The value of Ve / Vt for solubilized tilapia hepatic G H receptor was compared to 
the selectivity curve for Sepharose 4B in 25 m M Tris-HCl buffer (containing 0.1 % triton 
X-100, p H 7.2). Thyroglobulin ( M W 669,000)，apoferritin ( M W 443,000), B-amylase ( M W 
200.000)，ovalbumin ( M W 45,000) and carbonic anhydrase ( M W 29,000) were used to 
constructed the selectivity curve. The molecular weight of solubilized tilapia hepatic G H 
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Fig. 3.17 Affinity chromatography of 12 mg solubilized tilapia liver membrane proteins 
on Con A-Sepharose. 
Column dimensions : 10 x 1.6 cm. Flow rate : 10 ml / hr. Fraction size : 1 ml. 
Starting buffer : 25 m M Tris-HCl buffer (pH 7.2) containing 1 m M CaCia，0.5 M NaCl and 
0.1 % Triton X-100. The first arrow represents the point of application of 0.1 M a-methyl-
D-mannoside in the starting buffer. The second arrow represents the point of application 
of 0.3 M a-methyl-D-mannoside in the starting buffer. The column effluent was monitored 
by absorbance at 280 n m and receptor binding activity was expressed in term of % of the 
radioactivity of ^^^I-tGH added. The size of aliquot of column fractions used for 
radioreceptor assay was 200 ul. 
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Fig. 3.18 Affinity chromatography of 263 mg solubilized tilapia liver membrane proteins 
on Con A-Sepharose. 
Column dimensions : 10 x 1.6 cm. Flow rate : 10 ml / hr. Fraction size : 1 ml. 
Starting buffer : 25 m M Tris-HCl buffer (pH 7.2) containing 1 m M CaClp，0.5 M NaCl and 
0.1 % Triton X-100. The arrow represents the point of application of 0.3 M a-methyl-D-
mannoside in the starting buffer. Fractions 146-210 were pooled to form fraction Con A 
II. Fraction Con A II (200 ug protein) exhibited 0.7 % specific ^ ^^I-tGH binding whereas 
fraction Con A I did not show any binding activity. • 
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Fig. 3.19 Ion-exchange chromatography of 10 mg fraction Con A II of solubilized tilapia 
liver membrane proteins on a DEAE-BioGel A column. 
Column dimensions : 10 x 1.6 cm. Flow rate : 10 ml / hr. Fraction size : 1ml. 
Starting buffer : 25 m M Tris-HCL buffer (pH 7.2) containing 0.1 % Triton X-100. The 
arrow represents the point of application of 2.5 M NaCl in the starting buffer. Fractions 
80-110 were pooled to form fraction Con A II-DEAE II. Fraction D E A E II (200 ug 
protein) exhibited 2.1 % specific I-tGH binding whereas fraction D E A E I did not show 
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Fig. 3.20 Gel filtration of 0,3 mg Con A II-DEAE 11 fraction of solubilized tilapia liver 
membrane proteins on a Sepharose 4B column. 
Column dimensions : 100 x 1 cm. Flow rate : 7 ml / hr. Fraction size : 1 m l 
Buffer : 25 m M Tris-HCl, p H 7.2，containing 0.1 % Triton X-100. The column effluent was 
monitored by absorbance at 280 n m and receptor binding activity was expressed in term of 
% of the radioactivity of ^ ^^I-tGH added. The size of aliquot of column fractions used for 
radioreceptor assay was 200 ul. Fractions 55-58 was pooled to form fraction Con A II-
D E A E Il-Sepharose 4B. | 
I 
63 
f fr 讯 十 v • ~ 一 一 
A B C D E F G H I J - ^ 
IWMili < 205 K ; , 
• I |J i n i ,16 5 K 
, K S ^ ^ ^ , 1 5 5 K 
1 1 1 . r 1 --i 
^ ^ A j j A m i L ^ v M b ^ ^ 一 秦 ”16K 
llHllI 
十 
Fig. 3.21 Electrophoretic patterns of chromatographic fractions derived from solubilized 
tilapia hepatic membrane proteins. 
Samples were run on 5 % polyacrylamide gel containing 0.1 % SDS at a constant 
current of 10 rtiA and stained for proteins with the silver staining method as described in 
Materials and Methods. Lanes A and J : solubilized tilapia hepatic membrane proteins (28 
and 14 ug protein respectively); lane B : fraction Con A I (28 ug protein); lanes C and I 
:fraction Con A II (28 ug and 14 ug proteins respectively); lanes D and H : fraction Con 
A II-DEAE II (28 ug and 14 ug protein respectively); lane E : fraction Con A II-DEAE II-
Sepharose 4B (14 ug protein); lane F : protein standard M W markers (Sigma) including 
myosin ( M W 205 K), B-galactosidase ( M W 116 K)，phosphorylase b ( M W 97 K), bovine 
serum albumin ( M W 66 K), ovalbumin ( M W 45 K) and carbonic anhydrase ( M W 29 K); 
lane G : a，B and B'subunits of E . 她 RNA-polymerase (Pierce) with M W s of 39 K, 155 
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Fig. 3.22 Selectivity curve of SDS-polyacrylamide gel electrophoresis. 
The mobilities of the molecular weight standards in SDS-polyacrylamide gel 
electrophoresis (Fig. 3.21) were used to construct the selectivity curve. Relative mobility 







Distribution of b G H binding sites among various tissues in tilapia 
In chapter 1 the biological actions of bovine growth hormone (bGH) have been 
demonstrated in tilapia. They included anti-insulin activities such as elevation of serum 
levels of amino acids and glucose, depletion of hepatic glycogen content and reduction of 
hepatic glycogen synthetase activity. The results suggested the presence of target tissues for 
bovine growth hormone and hence it was necessary to identify the possible target tissues 
for G H in tilapia. 
G H binding sites have been well characterized in rat liver (Husman et al” 1988) and 
rabbit liver (Spencer et al, 1988). The structural similarity between growth hormone and 
prolactin (PRL) suggests that some similar biological actions are elicited by the hormones. 
The reproductive role of P R L in mammals and its high specific binding to mammalian 
gonads suggests that the gonad is a target organ of P R L (Koppelman and Dufau, 1982). 
The relatively high specific binding of oPRL to tilapia testis (2.1 % ) and ovary (2.8 % ) was 
suggestive of a reproductive role of P R L in tilapia (Edery et al, 1984). Exogenous P R L 
treatment reduced the osmotic permeability of gills, urinary bladder, kidney and intestine 
in several teleost species (Loretz and Bern, 1982) and these osmoregulatory organs bound 
oPRL，although with a relatively low (1-2 % ) specific binding (Edery et al, 1984). It was 
important to know whether growth hormone would carry out these functions and bind 






Ill both female and male tilapia, the specific ^ ^^1-bGH binding in various tissues was 
very low (below 1 % ) except in case of the liver (3.5 %). The data suggest that binding 
sites for b G H were absent from the gonads, the alimentary canal, gill filaments, kidneys, 
gas bladder, muscle, spleen and heart and that liver was the major target tissue of b G H . 
Some of the metabolic effects of b G H in tilapia appeared to be due to an action of the 
hormone on the liver. The somatomedin hypothesis states that in the mammal, growth 
hormone acts on the liver to produce somatomedin, which mediates the biological actions 
of growth hormone. Whether the same mechanism operates in tilapia remains to be 
elucidated. The specific binding of ^ ^^I-bGH to tilapia liver membranes was only about 
3.5 % of the added radioactivity, much lower than the non-specific binding which was as 
high as 3.6-10.7 % . It may have been due to the use of a non-homologous hormone (bGH) 
instead of tilapia G H as the ligand in the radioreceptor assay. In both sexes of tilapia the 
liver was the major ^^^I-bGH binding tissue. There were no significant differences in the 
distribution of GH-binding sites between male and female tilapia. Hence a random pool 





Kinetic studies of the binding of labelled growth hormones 
The data of inhibition of ^ ^^I-bGH binding to tilapia and rat liver membranes by cold 
b G H were used for Scatchard analysis (Scatchard, 1949). The maximum binding (Bmax) 
and dissociation constant (Kd) were estimated with the assumption of a single binding site. 
The binding site for ^^^I-bGH on tilapia liver membranes had a Bmax value of 180 
fmole/mg protein and a Kd value of 13 nM，whereas the binding site for ^ ^^I-bGH on rat 
liver membranes had a Bmax value of 600 fmole/mg protein and a Kd value of 2.5 nM. 
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The binding characteristics of G H receptor on rat liver membranes were comparable to 
those of i25l-human G H binding to rabbit liver membranes with a Bmax of 1300 fmole/mg 
and Kd of 1.1 n M (Tsushima, 1980)，and the binding of ^ ^^I-bGH to solubilized rabbit 
hepatic G H receptor with a Bmax of 219 fmole/mg and a Kd of 1.4 n M (Herington and 
Veith, 1977). The tilapia hepatic G H binding site thus appeared to have a relatively low 
affinity and binding capacity for radioiodinated mammalian G H than rat and rabbit liver 
membranes. It was most probably due to the heterologous nature of the mammalian G H 
ligand because in the case of the homologous assay system, the binding capacity of 
tilapia G H to tilapia liver membranes was much higher (Bmax = 390 fmole/mg) and the 
affinity was also higher (Kd = 2.5 n M ) than the corresponding data obtained by using 
b G H as ligand. The Bmax value was comparable in order of magnitude to that (125 
fmole/mg) obtained by Fryer (1979a) who has conducted a similar binding study using 
tGH and tilapia liver membranes, but there was a difference in Kd (0.067 nM). For the 
solubilized tilapia hepatic G H receptor, the Bmax was 360 fmole/mg and the Kd was 3.9 
n M . The values were comparable to the binding data of ^ ^^I-bGH to solubilized rabbit liver 
) 
( 
receptor (Herington and Veith, 1977). 
The binding capacity of ^ ^^I-tGH to tilapia liver membrane could be affected by two 
factors. Firstly, G H receptor occupancy by endogenous G H may decrease the number of 
free GH-binding sites in tilapia liver. Estimation of the total number of GH-binding sites 
requires in vitro desaturation of the receptors, which are occupied by the endogenous 
hormone, with MgCl?. Edery et al. (1984) showed that in both tilapia testis and ovary 
membranes in vitro desaturation by MgCl^ produced a 2-fold increase in specific binding 
of i25I-oPRL，indicating that a large proportion of receptors might be occupied by 
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endogenous prolactin. Secondly, the possibility of down-regulation of G H receptors by 
endogenous G H exists. Therefore, a limited number of G H receptors would be sufficient 
j 
for a full response to G H . ‘ 
Specificity of ^ ^^I-bGH binding to tilapia hepatic GH-binding sites 
It is important to note that when ^^^I-bGH was used as ligand, the rat hepatic G H 
receptor could distinguish b G H from oPRL readily. However, the tilapia hepatic G H 
receptor could not distinguish between b G H and oPRL, although it could differentiate 
tPRL from tGH . The potency of tGH was slightly lower than that of b G H . Despite the 
fact that tPRL had been shown to possess structural features in common with both tGH and 
b G H and demonstrated slight activity in the rat tibia bioassay (Farmer et al, 1977)，a high 
degree of specificity of binding of tGH to the tilapia hepatic G H receptor was observed in 
the present study. The seemingly anomalous behavior of oPRL may have been due to its 
heterologous nature since the experiment had been performed two times and the results 
were reproducible. 
Specificity of ^ ^^I-tGH binding to tilapia hepatic binding site 
1 oc 
When I-tGH was used as ligand, tilapia liver membranes and solubilized tilapia 
hepatic membrane proteins were able to differentiate b G H , oPRL as well as tPRL from 
tGH. Although b G H could slightly inhibit ^ ^^I-tGH binding, both tilapia liver membranes 
and solubilized hepatic receptors were able to differentiate tGH from the mammalian G H 
readily. 
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The present data suggest the existence of separate binding sites for prolactin and 
I 
growth hormone in tilapia liver, because tilapia prolactin was much less potent than tilapia 
growth hormone in inhibiting the binding of ^^^I-bGH or ^^^I-tGH to tilapia liver 
membranes or solubilized liver membrane proteins. Edery et al. (1984) observed that b G H 
was much less potent than tilapia and ovine prolactins in inhibiting the binding of 
oPRL to tilapia liver membranes. Fryer (1979b) showed that tilipia kidney membranes but 
not liver membranes were capable of binding ^ ^^I-tPRL and that tGH was much less potent 
than tPRL in inhibiting the binding of ^ ^^I-tPRL to tilapia kidney membranes. Their data 
are consistent with the notion of distinct prolactin and growth hormone receptors in tilapia 
liver. Our observation of ^ ^^I-bGH binding sites on tilapia liver membrane is in contrast 
to the negative finding of Tarpey and Nicoll (1985). The reason for this discrepancy is 
unclear. However, our observation of ^^^I-bGH binding sites is consistent with the 
demonstration of ^ ^^I-tGH binding sites in tilapia liver. 
Effect of enzyme treatments on tilapia hepatic GH-binding sites 
Treatment of tilapia liver membranes with trypsin and chymotrypsin that disrupt the 
structure of membrane proteins, caused a marked decrease in specific binding of ^ ^^I-tGH, 
suggesting that the tilapia hepatic GH-binding site was protein in nature and that the 
integrity of receptor protein structure was essential for G H binding. The absence of any 
effect of ribonuclease, deoxyribonuclease and neuraminidase on G H binding suggested that, 
if nucleic acids and sialic acid residues were present in the tilapia hepatic GH-binding site, 
they were not involved in G H binding. It is pertinent to point out here that the rat hepatic 






hormone receptor (Tsushima, 1980) also react similarly with the various enzymes used in 
the present study. 
Effect of p-chloromercuribenzene sulfonate (TCMBS) on tilapia hepatic GH-binding sites 
Inhibition of rat liver lactogenic receptor binding of ^ ^^I-oPRL by the presence of 
P C M B S in the assay medium has been reported by Silverstein and Richards (1979). 
Inhibition of ^ ^^ I-ovine P R L binding to rat hepatic lactogenic receptor but not ^^^I-bGH 
binding to rat hepatic somatogenic receptor by P C M B S has been reported (Tsim and 
Cheng, 1984). Inhibition of ^ ^^I-tGH binding to tilapia hepatic somatogenic receptor was 
observed in the present study, suggesting that although a reactive sulfhydryl group was not 
present in rat liver somatogenic receptor, it was present in tilapia liver somatogenic receptor 
and rat liver lactogenic receptor. 
The possibility existed that chemical modification by the thiol group-reactive reagent 
P C M B S brought damage to the membrane and hence the observed inhibition of tilapia 
somatogenic receptor binding was only an artifact of general membrane structural changes. 
I 
However, this was unlikely because the P C M B S inhibition of somatogenic receptor binding 
was a reversible process. The inhibited and then recovered receptor showed no difference 
from the control. Nevertheless, it was possible that reaction of P C M B S with a sulfhydryl 
group occurred at a distant site on the receptor and this reaction subsequently inhibited 
hormone binding through an allosteric mechanism. Likewise, it was not possible to rule out 
effects of P C M B S on other proteins present in the crude membrane preparation used in the 
present study. 
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Partial purification and characterization of solubilized tilapia hepatic G H receptor 
Tilapia hepatic G H receptor could be solubilized by the non-ionic detergent Triton 
X-100. The binding affinity (1/Kd) and binding capacity (Bmax) of ^ ^^I-tGH to tilapia liver 
membranes were comparable to the same parameters for the solubilized hepatic receptor. 
The solubilized tilapia hepatic G H receptors had a Kd of 3.9 n M and a Bmax of 360 
fmole/mg, whereas the tilapia liver membranes had a Kd of 2.5 n M and a Bmax of 390 
fmole/mg. 
In each of the chromatographic steps that the solubilized tilapia hepatic membrane 
proteins were subjected to, 0.1 % Triton X-100 was included in the eluting buffer in order 
to prevent aggregation of the solubilized receptors. The radioreceptor assay using 
tGH as ligand was used to monitor the G H binding activity of the column effluent. The 
！ 
final Triton X-100 concentration in the incubation mixture of radioreceptor assay was 0.1 
This concentration of Triton X-100 should not have affected the GH-binding activity 
as Tsushima (1980) has reported that Triton X-100 at concentrations up to 0.5 % had no 
effect on the binding of iodinated human G H or b G H to solubilized rabbit hepatic receptor. 
The solubilized tilapia hepatic membrane proteins were initially fractionated by 
affinity chromatography on a Con A-Sepharose column. Only the adsorbed fraction showed 
specific i25i_tGH binding suggesting that the tilapia hepatic G H receptor was glycoprotein 
in nature. The recovery of activity was only 2.13 % in contrast to the report of Tsushima 
(1980) that 60 % of the GH-binding capacity of the solubilized hepatic receptor was 
recovered after the Con A-Sepharose chromatography step. The specific GH-binding 
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activity of the hepatic receptor protein after Con A-Sepharose column chromatography was 
not enhanced but reduced by approximayely 50 % instead. It appears that the removal of 
I 
some non-glycoproteins from the detergent-solubilized membrane receptors somehow 
reduced the binding of ^ ^^I-tGH. 
When the Con A II fraction was further fractionated by ion-exchange 
chromatography on DEAE-BioGel A, only the adsorbed fraction showed specific binding 
125 
of I-tGH. A marginal increase in specific GH-binding activity was observed. It suggests 
that the tilapia hepatic G H receptor protein contained many anionic residues at neutral pH. 
Gel filtration on a Sepharose 4B column was used to further purify the Con A II-
D E A E II fraction and to determine the molecular weight of the solubilized tilapia hepatic 
G H receptor. The ^^^I-tGH binding activity was detected in the position corresponding to 
a molecular weight of about 400,000 in the column effluent. It was consistent with the 
previous finding that the M W of GH-binding activity from 7 mg solubilized tilapia liver 
membrane proteins was about 400,000 as estimated by gel filtration on Sepharose 4B, 
assuming that the hepatic G H receptor protein and the molecular weight marker proteins 
(thyroglobulin, apoferritin, B-amylase, ovalbumin and carbonic anhydrase) have the same 
symmetry. 
The present scheme of isolation of tilapia hepatic G H receptor from solubilized 
hepatic membrane proteins involving successive chromatography on Con A-Sepharose, 
D E A E BioGel A and Sepharose 4B was not very efficient because there was only 0.35 % 
recovery of GH-binding activity and 3-fold increase in specific GH-binding activity. On the 
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other hand, a single step of chromatography of the solubilized hepatic membrane proteins 
I 
on a Sepharose 4B column could bring about a 2-fold increase of specific GH-binding 
activity and 5.8 % recovery of GH-binding activity. The final preparation of tilapia hepatic 
G H receptor was still heterogenous as judged by its electrophoretic pattern although it was 
purified over the preparation of solubilized tilapia hepatic membrane proteins as judged by 
their electrophoretic profiles. Nevertheless, the present study provided several important 
pieces of information about the tilapia hepatic G H receptor such as the molecular weight, 
glycoprotein nature and the presence of many anionic residues at neutral pH. The use of 
affinity chromatography on a column of immobilized tGH should be attempted in the future 





Chapter 4 Soinatomedin-C or Insulin-like growth factor-I (SinC / IGF-I) 
Introduction 
Somatomedin is defined as a growth hormone-dependent hormonal peptide which 
mediates the actions of growth hormone. It was first designated as "sulphation factor" 
because it could stimulate sulphate incorporation into cartilage. In 1983, somatomedin C 
(SmC), one type of somatomedins, was found to be completely identical to insulin-like 
growth factor-I (IGF-I). Insulin-like growth factor-I is one of the components of the serum 
insulin-like activity orginally described as non-suppressible insulin-like activity (NSILA) (for 
reviews see Daughaday, 1989; Daughaday et al.，1989; Baxter, 1988; Baxter and Martin, 
1989; Clemmons, 1989; Barnes and Sirbasku, 1987; Froesch et al” 1985a; Rechler and 
Nissley, 1985). 




The complete structures of IGF-I and IGF-II have been elucidated. Human IGF-
I is a basic peptide which contains 70 amino acids and possesses a molecular weight of 7.65 
K. IGF-II is a neutral peptide which contains 67 amino acids and possesses a molecular 
weight of 7.47 K，and it has over 60 % homology to IGF-I (Riuderknecht & Humbe 1978a， 
1978b). Although IGFs were identified as non-suppressible insulin-like activities (Baxter 
1986)，they resembled insulin in structure, possessing about 48% amino acid sequence 
homology to human pro-insulin, and in some biological actions (Froesch & Zapf，1985). 
The A and B chains of IGFs are similar to those of pro-insulin, being joined by two 
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disLilphide bridges and a connecting peptide corresponding to the C peptide of pro-insulin. 
They are quite different from insulin because the C peptide will not be cleaved away, and 
has a short extension termed D peptide at the carboxyl-terminus of the A region. As 
deduced from the cDNAs coding for precursors forms of IGFs (Dull et al” 1984; Jansen et 
al” 1985; Bell et al” 1986)，the pre-prohormone contains a signal peptide of 25 amino acids 
at the amino-terminus of B region and a carboxyl-terminal extension termed E region. 
Receptors for IGFs 
The receptors of IGF-I and IGF-II are quite different in structure although there is 
a high homology in IGFs themselves (Rechler et al., 1985). IGF-I receptor resembles the 
insulin receptor, which is a heterotetrameric structure with 2 alpha (extracellular) and 2 
beta (transmembrane) domains. This receptor shows a primary specificity to IGF-I but 
shows up to 50% cross-reactivity with ipF-II and about 1 % cross-reactivity with insulin. 
I 
The alpha subunit contains IGF binding sites, and the intracellular portion of beta subunit 
contains a tyrosine-specific protein kinase and is capable of autophosphorylation. IGF-II 
receptor is a single polypeptide chain. It shows primary specificity to IGF-II and only 
shows 1 % or less cross-reactivity with highly purified or recombinant IGF-I and no cross-
reactivity with insulin. 
Binding proteins for IGFs 
Besides the IGFs receptors, there is another circulating form of IGF binding 
proteins. Two classes of binding proteins have been found (Baxter et al, 1986): one is 
I 
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growth hormone-dependent, the other is growth hormone-independent. The growth 
hormone-dependent binding protein is folind predominantly in a 150 kD complex with most 
of the circulating IGFs (Moses et al” 1976，Daughaday et al, 1982). After acidification, 
this 150 k D complex yields an acid-stable growth hormone-dependent subunit of about 50 
k D with one binding site for IGF-I or IGF-II (Martin and Baxter, 1986). Another class is 
a 30 k D growth hormone-independent binding protein, which is unrelated to growth 
hormone secretion (Baxter and Cowell, 1987). 
The role of binding proteins is still poorly understood. An inhibitory action of the 
binding proteins has been suggested. Because the total concentration of IFG-I and IGF-II 
in human plasma is about 100 n M , approximately 1000 times (Baxter, 1986) higher than 
that of the concentration of insulin, their 5 % insulin-like potency (Guler et al, 1987) 
should contribute 50 times more insulin-like activity than insulin. However this activity is 
not expressed in vivo, probably due to the binding of IGFs to binding proteins which 
prevent the association of IGFs with their cell-surface receptors. Other evidences also 
support this inhibitory effect of binding proteins. IGF binding proteins prepared from 
human plasma, human amniotic fluid and rat liver-derived cell line have been shown to be 
inhibitory to IGF action, such as insulin-like activity in fat cell (Zapf et al, 1979), D N A 
synthesis in chick embryo fibroblasts (Knauer and Smith, 1980) and proteoglycan synthesis 
in rabbit chondrocytes (Drop et al, 1979). On the other hand, some evidences suggest that 
IGFs are stabilized by binding to the growth hormone-dependent binding proteins, which 
increase the half lives of IGFs from 10-20 minutes to more than 4 hours (Zapf et al, 1985) 
and potentiate the effect of IGFs on the target sites. Human plasma IGF binding proteins 






binding protein secreted from cultured hilman fibroblasts actually increases the IGF binding 
to cell-surface receptors (Clemmons et al., 1986) and a purified amniotic fluid binding 
protein potentiates the effect of IGF-I in stimulating D N A synthesis in porcine smooth 
muscle cells and chicken, mouse and human fibroblasts (Elgin et al” 1987). 
Somatomedin hypothesis 
IGF-I (somatomedin C) was widely studied because it was first identified as mediator 
of the somatogenic actions of growth hormone (Daughaday et al, 1972). Previously, the 
somatomedin hypothesis postulated that IGF-I (somatomedin C) was the circulating 
compound that regulated skeletal growth under the influence of growth hormone. There 
are some evidences supporting the somatomedin hypothesis. Sulphate incorporation into 
cartilage is dependent on growth hormone (Salmon & Daughaday, 1957). Perfusion of 
isolated rat liver with growth hormone enhances somatomedin activity in the perfusate 
(Daughaday et al, 1976). A long delay (6-12 hours) in the appearance of somatomedin 
after growth hormone treatment is consistent with an effect of growth hormone on its 
synthesis (Copeland et al., 1980). Liver somatomedin activity falls in response to metabolic 
stress before a decrease in circulating level occurred (Vassilopoulou et al” 1984). IGF-I 
resembles growth hormone in stimulating the growth of hypophysectomized rats in a dose-
dependent manner (Schoenle et al., 1982). Growth hormone increases liver somatomedin 
(Schalch et al., 1979)，liver somatomedin m R N A (Norstedt et al” 1987) and plasma 
somatomedin level (Davis et al., 1987)，and somatomedin suppresses growth hormone 
secretion and m R N A levei in pituitary cells (Shunichi et al” 1986), suggesting that 






through the growth hormone-somatomedin axis at the level of anterior pituitary. 
However, recent studies suggested that IGF was more likely a local growth factor 
rather than a circulating mediator of growth hormone. IGF-I (SmC) can be generated 
locally by many cell types, ie. placental fibroblasts (Fant et al, 1986)，fat cells (Bolinder et 
al.，1987)，Sertoli cells and granulosa cells (Benahmed et al, 1987). Its presence in serum 
may not have physiological importance in most instances because the abundant binding 
protein of IGF-I would blunt its biological activities in serum. Growth hormone increases 
the cellular content of IGF-I m R N A in adipose tissue, suggesting that IGF-I has a 
paracrine/ autocrine role during adipose tissue development (Doglio et al” 1987). IGFs 
produced by the placenta act locally to regulate placental growth (Fant et al., 1986). 
Recombinant human IGF-I has biological activities in regulating blood glucose and 
membrane transport in the hypophysectomized rat but shows little growth-promoting activity 
(Skottner et al” 1987). The stimulating effect of local administration of growth hormone 
on longitudinal bone growth suggests the direct effect of growth hormone other than the 
I 
indirect effect through liver somatomedin C (Isksson et al, 1982). 
Biological activities of IGF-I 
Three classes of IGFs actions have been identified: metabolic, mitogenic and 
differentiative effects. The metabolic effects are basically the anabolic insulin-like actions 
such as stimulation of glucose uptake and utilization, glycogen synthesis and amino acid 
transport. Administration of IGF-I into rats or humans elicits a hypoglycaemic response 
similar to that caused by insulin (Zapf et al” 1985; Guler et al.，1987) with 6 % of the 
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potency of insulin. In some cell types such as fat cells, the insulin-like action may be 
mediated by cross-reactivity with the insulin receptor, whereas in other cell types the IGF-
I receptor appears to be the mediator (Froesch and Zapf, 1985). 
The mitogenic effects such as cell proliferation, D N A , R N A and protein synthesis 
are stimulated by both IGF-I and IGF-II (Baxter, 1986). However, the proliferation of 
lymphocytes appears to be inhibited by IGF-I (Hung and Eardley, 1986) and the mitogenic 
effect of IGFs in mouse BALB/c 3T3 fibroblasts is synergistic with platelet-derived growth 
factor (PDGF), which is required to make the cells competent before the IGFs can 
stimulate D N A synthesis (Stiles et al” 1979). The mitogenic effects are due to the 
interaction of both IGF-I and IGF-II with the IGF-I receptor, but the IGF-II receptor may 
have a similar role in some tissues. The somatic growth effect can be demonstrated by IGF 




The differentiative effects are only recently been recognized. Both IGF-I and IGF-
II stimulate myoblast differentiation to myotubes (Schmidt et al” 1983)，and rat IGF-II 
stimulate neurite formation in chick sensory neurons (Bothwell, 1983). In the reproductive 
system，IGF-I acts syngergistically with follicle-stimulating hormone to increase c A M P 
production and stimulate steroidogenesis in granulosa cells. Similar effects have been 
observed in the testis (Lin et al, 1986)，adrenal cortex (Morera et al, 1986) and thyroid 
gland (Tramontane) et al, 1986). It suggests that the full expression of the activities of some 
pituitary hormones on their target tissues (gonad, adrenal, thyroid) may require the 








Three radioligand assays (protein-binding assay of IGF, RIAs of IGF-I and IGF-II， 
radio-receptor binding assays of IGF-I and IGF-lI using rat liver membranes or rat 
placental membranes) and two bioassays (fat cell assay and assay measuring tf-thymidine 
incorporation into chick embryo fibroblasts) can be used to detect IGF-I and IGF-II in 
various mammals (Zangger et al., 1987; Wilson and Hintz, 1982). 
There is little information about the presence of IGFs in non-mammalian species. 
The cartilage sulphate uptake assay is successful in detecting IGF in mammalian and several 
non-mammalian species such as turtle, chicken, duck, toad, dogfish and skark (Van den 
Brande et al, 1974; Shapiro and Pimstone, 1977). However, the presence of IGF-I in fish 
is controversial. Van den Brande et al. (1974) found that carp (Cyprinus carpio) plasma 
did not stimulate ^ S^ uptake by porcine, rat and human cartilages, suggesting that there was 
no somatomedin-like substance in carp plasma. Similarly, Wilson and Hintz (1982) found 
no IGF-I-like immunoreactivity and IGF-I radio-receptor binding activity in hagfish, shark 
and carp sera, whereas the serum was first chromatographed on Sephadex G-50 in 0.25 M 
formic acid, (pH 2.3) to remove IGF binding proteins. Furlanetto et al. (1977) found that 
Atlantic blue fish serum did not cross-react in a human IGF-I radioimmunoassay. On the 
other hand, Lindahl et al. (1985) found that Baltic salmon serum cross-reacted in a IGF_ 
I radioreceptor assay using human placental membranes but only showed slight activity in 
IGF-I RIA, and the serum levels of IGF-I were higher during smoltification than the levels 
prior to or after the period of smoltification. It suggested that IGF-I was involved in the 
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process of smoltification. Shapiro and Pimstone (1977) showed that dogfish and shark sera 
* 35 
stimulated S uptake by porcine cartilage. In the experiment of Komourdjian and Idler 
I 
(1978)，liver slices from intact rainbow trout stimulated ^^ S uptake by gill arch bone of 
hypophysectomized rainbow trout in vitro, and it could be enhanced by addition of a 
combination of porcine growth hormone and thyroxine to the incubation medium, indicating 
hepatic production of a SmC-like factor. Funkenstein et al. (1989) found that IGF-I-like 
immunoreactivity (about 17 n M ) was detected in gilthead seabream plasma, and the activity 
could be elevated by human growth hormone administration (1 ug/g fish). In the 
experiment, the IGF-I binding proteins were removed from the plasma by reverse phase 
chromatography on ODS-silica column, after acidification of plasma with 0.5 M HCl. 
Daughaday et al. (1985) found IGF-I-like immunoreactivity but not IGF-II radioreceptor 
activity in rainbow trout serum. Drakenberg et al. (1989) found that tilapia serum exhibited 
IGF-I activity in the human fetal brain radioreceptor assay but no IGF-I immunoreactivity 
or IGF-II activity in the rat liver radioreceptor assay, and found that the apparent 
molecular weight of the IGF-I-like activity was approximately 7,000. 
If IGF-I is present in non-mammalian species, it suggests that the action of growth 
hormone could be partly mediated by a IGF-like peptide in these vertebrates. The 
mechanism which regulated IGF production in teleosts was still unknown but it was possible 
that，as in mammals, it mediates the growth effect of growth hormone. Since the data 
concerning insulin-like growth factor I in fish was controversial, it was unclear whether IGF-
I was also present and mediated the growth promoting action of growth hormone. The 





Materials and Methods 
Extraction of somatomedin C from tilapia serum and tissues 
Serum acidification and purification on the octadecasilyl (ODS)-silica column 
separate somatomedin C from its binding proteins. Briefly, the ODS-silica column was 
washed successively with 5 ml isopropanol, 5 ml methanol and 5 ml 4 % acetic acid. Two 
hundred microliters of tilapia serum were acidified with 1 ml 0.5 M HCl before application 
to the column. The column was then washed 2 times with 10 ml 4 % acetic acid and 
somatomedin C was eluted with 4 ml methanol. The methanol-extracted sample was 
evaporated to dryness and dissolved in 300 ul RIA buffer for RIA using a somatomedin C 
RIA kit (Incstar). 
A similar technique was applied in extracting various tilapia tissues. Briefly, the liver 
(Ig)，gonad (Ig) or muscle (2g), collected from 2 fish, were homogenized in 5 ml 0.5 M ice-
I 
cold H C L Other tissues including the kidney, heart, brain, spleen and pituitary were pooled 
from 10 fish because of their small size. The homogenates were centrifuged at 20,000 g for 
1 hour. The resulting supernatant was subjected to somatomedin C extraction using ODS-
silica column. 
Somatomedin C radioimmunoassay (RIA) 
Somatomedin C was assayed by using a ^^^I-somatomedin C RIA kit (Incstar 
corporation). Briefly, 50 ul of the ODS-silica-extracted sample was incubated with 200 ul 
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rabbit anti-human S m C serum at 4°C for 16 hours. Two hundred microlitre ^^^1-human 
synthetic S m C (13,000 cpm) was then added and incubation proceeded for an additional 16 
hours. Goat anti-rabbit (GAR) precipitating complex (500 ul) was added to the mkture 
which was incubated for another 16 hours. After centrifugation at 5000 g for 1 hour, the 
resulting supernatant was decanted and the ^ ^^I-SmC bound to the antibodies was counted 
in a gamma counter. Human S m C was used as the standard. 
Characterization of tilapia serum somatomedin C 
Gel filtration on Sephadex G-50 was used to determine the molecular weight of 
tilapia serum IGF-I-like immunoreactivity. The Sephadex G-50 column was equilibrated 
with 0.1 M acetic acid and calibrated with molecular weight standards before the 
application of the ODS-silica-extracted serum. After application of the sample, 1-ml 
fractions were collected and the column effluent was monitored by U V absorbance at 280 
I 
I 
nm. The fractions were evaporated to dryness using a speed-vac apparatus and 






Detection of S m C in tilapia serum 
Tilapia serum exhibited a displacement curve which was parallel to the standard 
curve in S m C RIA. The concentration of SmC-like immunoreactivity in tilapia serum was 
about 4-9 n M (Fig. 4.1). 
Distribution of SmC-like immunoreactivity in various tilapia tissues 
The most abundant source of S m C was found in the liver, which contained 27.3 
pmoles SmC/ g liver (Table 4-1). The total hepatic content of S m C per fish was 49.4 
pmoles. The gonad and the kidney also contained relatively high concentrations of SmC, 
18 and 10 pmole/ g tissue respectively. Other tissues such as the heart, brain, spleen and 
muscle contained very low concentrations of S m C (0.96 - 6.3 pmoles/ g tissue). The total 
pituitary content of S m C was only 0.12 pmole on account of its small size. Although muscle 
contained a low concentration of SmC, its large mass accounted for a relatively high S m C 
content (28.8 pmoles). 
Gel filtration of tilapia serum S m C 
Tilapia serum which had been extracted by chromatography on ODS-silica column 
was fractionated by gel filtration on Sephadex G-50 column. Fig. 4.2 showed the SmC-like 








like immunoreactivity was 9,000, as calculated from the selectivity curve (Fig. 4.3). Some 
SmC-like immunoreactivity was also found in the void volume peak and its molecular 







Table 4-1 Level of IGF-I-like immunoreactivity in tilapia tissues 
Tissue N tissue wt/fish IGF-I IGF-I 
(g) (pmole/g tissue) (pmole/fish) 
liver 2 1.80 27.30 49.40 
gonad 2 0.53 18.0 9.60 
kidney 10 0.19 10.0 1.90 
heart 10 0.13 6.30 0.84 
brain 10 0.14 1.80 0.24 
spleen 10 0.06 4.90 0.29 
pituitary 10 - - 0.12 
I 
muscle 2 30.0 ; 0.96 28.80 
I 
IGF-I concentrations in tilapia tissues were measured by RIA as described in 
Materials and Methods. Tissues samples were pooled because they were small in quantity 
and N represented number of fish from which the tissues were pooled. Values were 
obtained from single measurements. The S m C RIA exhibited less than 0.01 % cross-
reactivity with IGF-II and rat multiplication stimulating activity (MSA). 
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Fig. 4.1 Tilapia serum somatomedin C radioimmunoassay. 
The standard curve was constructed using 0.7 to 40 ng somatomedin C. Different 
volumes of tilapia serum samples were extracted and purified by ODS-silica column 
chromatography before assay. Values are expressed as % of maximum binding (31 % of 
total radioactivity of ^ ^^I-somatomedin C added and represent means 土 S E M of duplicate 
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Fig. 4.2 Gel filtration of tilapia serum (3.6 ml) on Sephadex G-50 column. 
Column dimensions : 100 x 1 cm. Flow rate : 7 ml / hr. Fraction size : 1 ml. 
Eluent: 0.1 M acetic acid. The column effluent was monitored by somatomedin C-like 
immunoreactivity. Chymotrypsinogen A ( M W 25,000), cytochrome C ( M W 12,500), insulin 
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Fig. 4.3 Molecular weight estimation of tilapia serum somatomedin C-like 
immunoreactivity by gel filtration on Sephadex G-50 column. 
Chymotrypsinogen A ( M W 25,000), cytochrome C ( M W 12,500), insulin ( M W 6,000) 
and bacitracin ( M W 1,400) were used to construct the selectivity curve. The molecular 
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Fig 4.4 Gel filtration of tilapia serum (3.6 ml) eluted in the void volume of Sephadex G-
50 on Sepharose 4B column. 
Column dimensions : 100 x 1 cm. Flow rate : 7 ml / hr. Fraction size : 1 ml. 
Buffer : 100 m M ammonium acetate, pH 7. The column effluent was monitored by 
absorbance at 280 run and somatomedin C-like immunoreactivity. Thyroglobulin (TG) 
( M W 669,000), yeast alcohol dehydrogenase (ADH) ( M W 150,000), bovine serum albumin 
(BSA) ( M W 65,000), ovalbumin (Oval) ( M W 45,000), carbonic anhydrase (CA) ( M W 
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Fig 4.5 Molecular weight estimation of tilapia serum somatomedin C-like 
immunoreactivity eluted in the void volume of Sephadex G-50 by gel filtration on Sepharose 
4B column. 
Thyroglobulin ( M W 669,000), yeast alcohol dehydragenase ( M W 150,000), bovine 
serum albumin ( M W 65,000), ovalbumin ( M W 45,000)，carbonic anhydrase ( M W 29,000) 
and cytochrome C ( M W 12,500) were used to construct the selectivity curve. The 




Somatomedin C, also called insulin-like growth factor I (SmC/ IGF-I), is well 
characterized in mammals but there is little information about the presence of S m C in non-
mammalian species. The present study suggested the presence of a SmC-like peptide with 
an apparent molecular weight of about 9,000 as well as a high molecular weight SmC-like 
entity (45,000) in tilapia serum. The ability of tilapia serum to inhibit the binding of 
human IGF-I/ S m C to its antibodies with a dose-response curve indicates that tilapia S m C 
is immunochemically similar to human SmC. 
SmC-like immunoreactivity was detected in tilapia serum at a concentration of about 
4-9 nM. It was comparable to the finding that IGF-I (SmC)-like immunoreactivity was 
detected in rainbow trout serum at a concentration of about 1 n M (Daughaday, 1985). 
Funkenstein et al. (1989) also found 丨IGF-I (SmC)-like immunoreactivity in gilthead 
seabream plasma with a concentration of about 17 nM. 
Drakenberg et al. (1989) found that tilapia serum exhibited IGF-I activity in the 
human fetal brain radioreceptor assay but no IGF-I immunoreactivity or IGF-II activity in 
the rat liver membrane radioreceptor assay. Starvation reduced rat hepatic IGF-I m R N A 
expression and serum IGF-I level whereas refeeding caused both serum IGF-I level and 
IGF-I expression to increase within 6 hours (Emler and Schalch, 1987). However, 
Drakenberg et al. (1989) found that starvation and refeeding of tilapia caused significant 
changes in body weight but its effect on serum IGF-I level could not be established. 
I 
Although there was no IGF-I-like immunoreactivity found in tilapia serum by Darkenberg 
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et al. (1989)，IGF-I-like immunoreactivity was found in tilapia serum after acidification and 
ODS-silica column chromatography in the present study. These discrepancies in results may 
I 
be due to the use of different antibodies or the method of separation of IGF-I from its 
binding proteins. Drakenberg et al. (1989) incubated the tilapia serum in 2 M acetic acid 
at 4°C overnight. The sample was then separated on a Sephadex G-50 column in 0.1 M 
acetic acid. In the present study, ODS-silica column chromatography was probably more 
efficient in removing the binding proteins from IGF-I and hence facilitate the detection of 
IGF-I immunoreactivity. The present study showed that there was a lack of correlation 
between body weight change and serum S m C concentration (see chapter 5). The result are 
thus similar to those of starvation-refeeding study in Drahenbery et al. (1989). 
S m C was also present in tissues of tilapia other than the liver, such as the gonad, 
kidney, heart, brain, spleen and muscle. It was found in small quantities in the heart, brain 
and spleen but at relatively higher concentrations in the gonad and kidney. The S m C level 
in the pituitary was very low. This finding was comparable to that of D'Ercole and 
Underwood (1987) who noted that in the rat IGF-I (SmC) was present in different tissues. 
The highest concentration of IGF-I was detected in the kidney, liver, lung and testis. After 
hypophysectomy, IGF-I concentration fell to a very low level in the liver and to lesser 
extents in other tissues. After administration of ovine growth hormone (3 successive daily 
injections of 500 ug/ injection), the IGF-I concentration in the rat liver, kidney and lung 
increased 2 times whereas the serum IGF-I concentration remained unchanged. It 




Although the concentration of S m C in tilapia muscle was very low, a large mass of 
. ！ 
I 
muscle in the body accounts for a large total quantity of S m C which was just less than that 
present in the liver. The highest concentration and quantity of S m C was observed in the 
liver and suggested that it was the major source of S m C production in tilapia. To further 
investigate the S m C hypothesis, hypophysectomized tilapia should be used to study the 
response of serum SmC, liver S m C and rate of S m C - m R N A synthesis after growth hormone 
administration. 
In the present study, tilapia serum SmC-like activity could be attributed to two 
groups of materials, one group with an apparent molecular weight of 9,000 and another 
group with a high molecular weight activity of about 45,000. Drakenberg et al. (1989) have 
been reported that tilapia serum exhibited IGF-I (SmC)-like activity in the human fetal 
brain radioreceptor assay but no IGF-I (SmC)-like immunoreactivity was detected. The 
radioreceptor binding activity was due to two groups of materials: one group with a 
molecular weight of 7,000 and another group with a high molecular weight of above 
250,000. The M W 9,000 SmC-like immunoreactivity in serum observed in the present study 
very likely corresponded to the M W 7,000 SmC-like receptor binding activity in tilapia 
serum by Drakenberg et al. (1989). The high molecular weight SmC-like immunoreactivity 
found in the present study could be a S m C binding protein because its large molecular 
weight (45,000) seems to exclude the possibility of it being a precursor of SmC. Human 
prepro IGF-I/ S m C possesses a molecular weight of 14,300 (Baxter, 1988). It was about 
the same size as the acid-stable subunit ( M W 50,000) of the human S m C binding protein 





The molecular weight 45,000 SmC-like immunoreactivity was detected after 
acidification and ODS-silica extraction of tilapia serum. It was smaller than the 250,000 
molecule found by Drakenberg et al. (1989) probably because the ODS-silica column 
extraction of serum was more efficient in dissociating the acid-stable subunit from the large 
binding protein complex than the method of Drakenberg et al. (1989). Since Drakenbery 
et al. obtained the large M W IGF-I radioreceptor binding activity in tilapia serum by gel 
filtration on Sephadex G-200 with neutral pH, the large binding protein complex would not 






Chapter 5 Effects of salinity and diet on somatic growth and secretion of hormones in 
tilapia 
Introduction 
Growth hormone has been demonstrated as a seawater-adapting hormone in 
rainbow trout (Bolton et al, 1987)，coho salmon (Clarke and Nagahama, 1977a), Amago 
salmon (Miwa and Inui, 1985) and Atlantic salmon (Komourdjian et al., 1976; Prunet et al., 
1989). Purified tilapia growth hormone , as well as bovine growth hormone and ovine 
prolactin, facilitated seawater adaptation of sockeye salmon, while tilapia prolactin had no 
effect (Clarke et al., 1977b). Although prolactin had been found to play a central role in 
freshwater osmoregulation in several euryhaline teleosts, including Oreochromis 
mossambicus (Bern, 1975; Nagahama et al, 1975; Nicoll et al” 1981)，the possible 
involvement of growth hormone in osmoregulation might be one of its important roles in 
fish. 
I I ] 
Plasma growth hormone level rose during smoltification in coho salmon (Sweeting 
et al., 1985) and in chum salmon after introduction into seawater (Hirano et al., 1987; 
Hasegawa et al., 1987). Growth hormone enhanced gill Na+，K+-ATPase activity in coho 
salmon (Richman and Zaugg, 1987; Bjornsson et al, 1987). Increase in plasma growth 
hormone levels occurred during smoltification in Atlantic salmon (Prunet et al., 1989) and 
coho salmon (Young et al, 1989). Histological studies of coho salmon pituitaries also 
indicated increased secretory activity of growth hormone cells during 
• 
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smoltification ^  (Clarke and Nagahama, 1977a; Nishioka et al., 1982). Growth hormone 
stimulated lipolysis from depot tissues and increased free fatty acid in the blood of goldfish 
(Minick and Chavin, 1970). It should be noted that growth hormone could not restore the 
I 
lipase activity to the original level in hypophysectomized fish, suggesting that growth 
hormone alone was not responsible for the endogenous high levels of lipase activity but 
growth hormone might also sensitize target organs to other lipolytic agents instead (Fain, 
1980). Since growth hormone enhanced the conversion of free fatty acid to acetyl CoA with 
subsequent utilization of the latter for energy (through the Krebs cycle), fat was utilized for 
energy in preference to both carbohydrate and protein (Goodman and Schwartz, 1974). 
The protein-sparing effect might be a major factor allowing protein deposition and growth 
during the energy-intensive process of smoltification. However, knowledge about the 
osmoregulatory role of growth hormone in non-salmonid fish was limited. Doneen (1976) 
found tilapia prolactin and human growth hormone effective in reducing Gillichthys urinary 
bladder water permeability, whereas tilapia growth hormone, rat and bovine growth 
hormones and human prolactin were ineffective. Helms et al (1987) found that the 
increase in medium osmotic pressure (from 285 or 320m0smol to 355 mOsmol) by 
addition of NaCl significantly enhanced release of growth hormone in vitro by the cultured 
tilapia pituitary. It was true in smaller fish (60g) but not in larger fish (120g) which had 
a higher spontaneous release of growth hormone and showed no response to the change 
in osmolality. Since the ages of the fish were not known, it remained unclear whether the 
observed size-related increase in spontaneous growth hormone secretion was related to the 
3 Salmon are anadromous; that is, they spend much of their lives at sea, then return 
to fresh water streams and lakes to spawn. After hatching in the spring, the young salmon 
remain in freshwater streams and lakes for about two years as they develop to a stage 
known as a smolt. This process is known as smoltification. The smolts then migrate 
downstream and into the sea, and enter a period of heavy feeding and rapid growth. 
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fish size, to the age or to the developmental stage. 
i 
I 
The effect of salinity in relation to fish culture have been extensively studied. Lam 
I 
and Sharma (1985) found that survival, growth and development of carp larvae (Cvprinus 
carpio) increased with increasing salinity from fresh water to 10 % sea water (3 parts per 
thousand salinity"^ ). Oxygen consumption increased in marine organisms transferred to 
diluted media, and also in freshwater organisms transferred to saline media (Madanmohan, 
1968; Parvatheswararao, 1965). This extra energy was utilized in osmoregulation in stress 
medium. Tilapia is an euryhaline species which successfully adapts over a wide range of 
salinity from fresh water to full strength seawater. It could reproduce in fresh water, 
seawater (33 ppt and 49 ppt salinity) (Popper et al” 1975) and hypersaline seawater (69 ppt 
salinity) (Potts et al, 1967). The reproductive performance of tilapia (Oreochromis 
spilurus) was better in brackish groundwater (3-4 ppt salinity) than seawater (38-41 ppt 
salinity). The fecundity in groundwater over the entire season was 2-5 times higher than 
that in seawater and the hatching rate was twice as high in groundwater as in seawater 
(Al-Ahmad et al., 1988). In tilapia (Oreochromis mossambicus). the blood glucose level, 
as well as oxygen consumption and cytochrome-oxidase activity, increased in stress media, 
such as 75% and 100% seawater (33 ppt salinity) (Bashamohideen et al, 1972). The 
oxidation of blood glucose was the predominant energy source for osmotic work in this 
stress media and it was in agreement with the depletion of muscle and liver glycogen 
observed. The drastic changes in blood glucose, liver glycogen and muscle glycogen were 
delayed until the salinity was increased over 50% seawater (16 ppt salinity), suggesting that 
tilapia could tolerate upto 50% seawater without any drastic change. 
4 Salinity is defined as the total amount of salts dissolved in seawater, which is 
measured in parts per thousand (ppt). 
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In the present experiments, the relationship between salinity and growth rate of 
tilapia (Oreochromis mossambiciis) was studied. From a preliminary experiment it was 
found that the growth was optimal in half seawater (15 ppt salinity) when compared to that 
in freshwater (0 ppt salinity) or in seawater (30 ppt salinity). This interesting phenomenon 
led us to investigate whether the enhanced growth was due to an elevation of endogenous 
growth hormone, which could be measured by a homologous radioimmunoassay. Cortisol 
and thyroxine were also involved in seawater adaptation. Thyroid hormones (Barron, 1986; 
Grau et al, 1985) and Cortisol (Hegab and Hanke, 1984; Barton et al., 1985; Young, 1986; 
Richman and Zaugg, 1987; Bjornsson et al, 1987; Young et al., 1989) together with 
prolactin (Parwez and Goswami, 1985) had been implicated in seawater adaptation. The 
increase in thyroid hormones and Cortisol levels during salmon smoltification (Young, 1986) 
was consistent with the depletion of lipid and carbohydrates associated with parr-smolt 
transformation (Woo et al., 1978). Cortisol enhanced gill Na+.K+-ATPase activity in coho 
salmon (Bjornsson et al” 1987; Richman and Zaugg, 1987) and Altantic salmon (Langhorne 
and Simpson, 1986). Acclimation of carp (stenohaline and tilapia (euryhaline) to 
different salinities also resulted in an elevation of blood Cortisol level synchronous with the 
elevation of blood glucose level (Hegab and Hanke, 1984). Doneen (1976) found that 
1 
Cortisol increased water permeability dnd ion transport of Gillichthys urinary bladder 
I 
whereas prolactin reduced water permeability of the bladder. It was important that the 
Cortisol inhibiting action of prolactin was essential for teleost osmoregulation. There were 
evidences for a close functional relationship among growth hormone, thyroid hormones, 
5 Stenohaline species are those organisms which can only adapt and survive in a 
narrow range of salinities, in contrast to euryhaline species which can adapt to a wide 
range of salinities. 
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Cortisol and IGF-I/ SmC. Cortisol could stimulate growth hormone release from in vitro 
culture of tilapia pituitary (Helms, et al., 1987; Nishioka et al., 1985) and both growth 
hormone and thyroid hormones had stimulatory effects on the interrenal of coho salmon 
(Young, 1988; Young and Lin, 1988). Tilapia and ovine growth hormones could stimulate 
peripheral deiodination of T^ into T3 in eel (De Luza et al, 1989). Lindahl et al. (1985) 
reported that serum somatomedin level was higher during smoltification of Baltic salmon, 
the involvement of the action of growth hormone or somatomedin in seawater adaptation 
was important. However, since the radioimmunoassay for tilapia prolactin has not been 
worked out in our laboratory, prolactin could not be measured in the salinity experiment. 
The aim of the present study was to examine the effect of salinity on somatic growth and 
serum hormone levels. T h e hormones examined included growth hormone, Cortisol, 







Materials and Methods 
Tilapia, which was originally cultured in fresh water pond (in Marine Science 
Laboratory, Department of Biology, CUHK), was divided into 6 groups. Each group 
contained 20 fish weighing about 100 g. Three groups were fed artificial diet (Star Green 
Mini, Yeaster Company Limited, Japan) kt a dose of 0.5 % of the body weight per day and 
! 
acclimated to 0 ppt (fresh water), 15 ppt (50 % seawater) and 30 ppt (100 % seawater) 
salinity, respectively. Before acclimation to 100 % seawater the fish had been transferred 
from fresh water to and kept in 50 % seawater for 2 days to avoid osmotic shock. Similarly 
another 3 groups were fed artificial diet at a dose of 1.5 % of the body weight per day and 
acclimated to 0 ppt (fresh water), 15 ppt (50 % seawater) and 30 ppt (100 % seawater) 
salinity, respectively. They were subjected to a photoperiod of 12 hours of light and 12 
hours of darkness and a water temperature of 25-30°C. The water in each group was 
refreshed twice a week. The initial average body weights of fish in each group were 
measured before treatment and they were used to compare with their final average body 
weights after 30 days of treatment. The average body weight was used because there was 
technical problems in identification of each individual fish in a whole group, hence the 
change in body weight was the % change of average body weight at the end of experiment 
in compare with their initial average body weight of a group. The change in body weight 
was used as a parameter for growth because of the change in body length was small and 
the measurement was hard to be accurate, whereas the change in body weight was greater 
which could be measured with higher accuracy. At the end of the experiment the fish were 
bled and muscle samples were collected to determine the water content. Serum samples 
were subjected to determination of tGH, IGF-I/ SmC, insulin, Cortisol, thyroxine, sodium 
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Hormonal levels in tilapia serum were measured by various hormone RIAs. Tilapia 
growth hormone (tGH) was measured by RIA using the double-antibody technique. Tilapia 
growth hormone (tGH), tilapia prolactin (tPRL), rabbit anti-tGH serum and rabbit anti-
tPRL serum for the RIA were gifts from Dr. H. Papkoff, University of California, San 
Francisco. Briefly, 200 ul tilapia serum or tGH standard was incubated with 30,000 cpm 
i25l-tGH (50 ul) and 50 ul rabbit anti-tGH serum (1/30,000 dilution) in 0.15 M NaaHPO^ 
buffer (containing 0.1 % BSA，0.1 % Triton X-100 and 0.01 % thimerosal, p H 7.4) in a 
total volume of 300 ul at 4°C. After 16 hours of incubation, 100 ul goat anti-rabbit serum 
(1/100 dilution) and 100 ul rabbit gamma globulin (1/1000 dilution) were added to the 
mixture in a final volume of 500 ul and then incubated for another 16 hours. The reaction 
was terminated by dilution with 1 ml of ice-cold 12 % (w/v) polyethylene glycol in 0.01 M 
NaaHPOq buffer (containing 0.15 M NaCl, p H 7.4). Separation of free and bound hormone 
was achieved by centrifugation at 5,000 g for 1 hour. The supernatant was decanted and 
the I-tGH bound to the antibodies was counted in a Beckman gamma counter. 
Serum IGF-I/ S m C level was measured using ^^ I^-IGF-I/ S m C RIA kit (Incstar 
corporation). Serum insulin, Cortisol and thyroxine were measured by ^^ I^-insulin, 
cortisol and thyroxine RIA kits (ICN Biomedicals, Inc.) respectively. Serum Na+ and 
K+ levels were measured by atomic absorption spectrometry after dilution of 50 ul serum 
to 2 ml. NaCl and KCl were used as the standards. Muscle water content was measured 
by drying the samples in an oven at 90。C until a constant weight was obtained. The muscle 
water content could be calculated from the differences between the final and initial weights. 
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Serum insulin level was measured using ^^ I^-insulin RIA kit (ICN Biomedicals 
Incorporation), 300 ul serum was incubated with 200 ul anti-human insulin serum (raised 
in guinea pig) at 4°C for 16 hours. Two hundred microliter ^ ^^ I-insulin (300,000 cpm)was 
added to the mixture which was then incubated for another 16 hours. One hundred ul 
precipitating antiserum (goat anti-guinea pig serum) was added to the mbcture which was 
further incubated for 16 hours. After centrifugation at 5,000 g for 1 hour, the supernatant 
was decanted and the ^ ^^ I-insulin bound to the antibodies was counted in a gamma counter. 
Serum Cortisol level was measured using ^^ I^-cortisol RIA kit (ICN Biomedicals 
Incorporation), 20 ul serum was added to the anti-cortisol-coated tube. (In this RIA, 
cortisol-3-o-carboxymethloxine-BSA was used as the antigen to generate the anti-serum in 
rabbit. This anti-serum was covalently bounded to the inner surface of a polypropylene 
tube.) One ml ^ ^^ I-cortisol (40,000 cpm) was added to the tube followed by incubation at 
37°C for 1 hour. The supernatant was decanted and the ^ ^^ I-cortisol bound to the antibody-
coated tube was measured in a gamma counter. 
Serum thyroxine level was measured using ^ ^^ I-thyroxine RIA kit (ICN Biomedicals 
i 
Incorporation), 100 ul serum was added to the anti-T^-coated tube. One ml (50,000 
cpm) was added to the tube and incubated at 37°C for 1 hour. After centrifugation at 
5,000 g for 1 hour, the resulting supernatant was decanted and the bound to the 
antibody-coated tube was counted in a gamma counter. 
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Results 
The results are presented in table 5-1. After 30 days of treatment, fish fed artificial 
diet at a daily dose of 1.5 % of the body weight had a greater increase in body weight than 
those fed a diet at a daily dose of 0.5 % of the body weight and kept in the same salinity. 
The growth rate of tilapia reared in fresh water and 50 % seawater was approximately 
double when they were fed the richer (1.5 % ) diet. In 100 % seawater the body weight 
loss was reduced when fish were fed richer diet. Regardless of the type of diet, the highest 
somatic growth occurred in 50 % seawater whereas the lowest somatic growth occurred in 
100 % seawater. Analysis of muscle water content revealed that there was no significant 
change in fish fed with different amount of diet at a given salinity, however a mild 
dehydration (1-4 % ) was observed in fish as the ambient salinity increased from freshwater 
to 50 % seawater or to 100 % seawater. Although the 1 % dehydration was observed in 
fish cultured in 50 % seawater, the highest growth rate was found in these fish. The 3-4 
% dehydration in fish cultured at 100 % seawater, however, could not fully account for the 
I 
drastic decrease in body weight. In table 5-1，the data within a column (same salinity) 
represent two groups of fish feeding at different dose of diet (0.5 % and 1.5 %), which are 
compared by Student's t test. 
Regardless of the type of diet, growth hormone secretion was maximal in 100 % 
seawater. At this salinity the serum growth hormone level was about double the level found 
in fish cultured in fresh water or 50 % seawater. The highest growth rate observed in fish 
cultured in 50 % seawater was not accompanied by a high circulating level of growth 
hormone. The amount of food in the diet did not seem to affect the serum level of G H . 
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The serum somatomedin C concentration did not vary significantly among the 
different groups. Although the highest serum concentration of growth hormone was found 
• . I 
in fish cultured in 100 % seawater, the s^mm S m C level in that group was not significantly 
I 
different from those of the other groups. The serum S m C concentration also did not 
significantly change in fish fed different diets. 
In fish fed either type of diet, the serum Cortisol level increased as the ambient 
salinity increased. The serum Cortisol level was also found to be dependent on the amount 
of food supply. The larger the amount of food given, the higher was the serum Cortisol 
level in fish cultured in a given salinity. 
In fish fed the 0.5 % diet, serum insulin concentration was the highest in 100 % 
seawater while there was no significant difference of serum insulin level between fish 
cultured in 50 % seawater and fish in freshwater. However, in fish fed the 1.5 % diet, the 
highest serum insulin level was found in fresh water, and there was no difference between 
fish cultured in 50 % seawater and fish in 100 % seawater. For fish cultured in 100 % 
seawater, increase in the amount of food in the diet caused a decrease in serum insulin 
level. For fish cultured in fresh water, however, an increase in serum insulin level was 
observed when the amount of food in the diet increased. For fish cultured in 50 % 
seawater, no significant difference in serum insulin concentration was found in tilapia fed 
different types of diet. Hence there was no simple corelation between serum insulin 
concentration and the amount of food supply or between serum insulin level and the 
ambient salinity. 
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In fish fed the 1.5 % diet, the serum thyroxine concentrations were similar in all 
1 
three different salinities. O n the other hand, in fish fed the 0.5 % diet, serum thyroxine 
level was the highest in fish cultured in 50 % seawater and the lowest in fish cultured in 
100 % seawater. Serum thyroxine level was not affected by the type of diet in fish cultured 
in 100 % seawater or fresh water. However, in fish cultured in 50 % seawater, the serum 
thyroxine level decreased as the amount of food in the diet increased. 
Regardless of the type of diet, serum sodium ion concentration increased and serum 
potassium ion concentration decreased as the ambient salinity increased. The 
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Fig. 5.1 Specificity of ^ ^^MGH radioimmunoassay. 
Competition for binding of ^ ^^I-tGH (expressed as % of maximum binding, in which 
maximun binding represented 33.0 % of the radioactivity of ^ ^^I-tGH added) was measured 
in the presence of increasing amounts of unlabelled hormone. Values represented means 
土 S E M of duplicate determinations. S E M is not shown in case it is smaller than 1 % . 
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Fig. 5.2 Tilapia serum t G H radioimmunoassay. 
Standard curve was constructed using 0.001 ng to 40 ng tGH. Tilapia serum samples 
were assayed at different volumes. Values were expressed as % of maximum binding (33 
% of radioactivity of ^ ^^I-tGH added) and represented means of duplicate determinations. 
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Fig. 5.3 Tilapia serum insulin radioimmunoassay. 
Standard curve was constructed using 0.25 fil.U. to 40 iilXJ. insulin. Tilapia serum 
samples were assayed using different volume. Values were expressed as % of maximum 
binding (38 % of radioactivity of ^ ^^ I-insulin added) and represented means of duplicate 
determinations. S E M is not shown in case it is smaller than 1 %。 
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Fig. 5.4 Tilapia serum thyroxine radioimmunoassay. 
Standard curve was constructed using 0.025 ng to 4.0 ng thyroxine. Tilapia serum 
samples were assayed using different volumes. Values were expressed as % of maximum 
binding (37 % of radioactivity of ^ ^^ I-thyroxine added) and represented means of duplicate 
determinations. S E M is not shown in case it is smaller than 1 % . 
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Fig 5.5 Tilapia serum Cortisol radioimmunoassay. 
Standard curve was constructed using 0.25 ng to 25 ng Cortisol. Tilapia serum 
samples were assayed using different volumes. Values were expressed as % of maximum 
binding (54 % of radioactivity of ^ ^^ I-cortisol added) and represented means of duplicate 
determinations. S E M is not shown in case it is smaller than 1 
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Table 5-1 Effects of salinity and diet on somatic growth and serum concentration of 
hormones and ions in tilapia 
100 % seawater 50 % seawater fresh water 
(0.5 % diet) 
body wt. change (%) -1,6 +7.9 +3:1 
muscle water (%) 72.0 土 0.8 ^  75.0 土 0.4 b 76.0 土 0.3 ^  
G H (ng/ml) 19.9 土 4.1 ^  5.2 土 1.7 ^  7.9 ± 1.8 ^  
S m C (nM) 4.7 土 0.8 ^  7.3 土 0.4 “ 9.3 土 0.8 匕 
Cortisol (ng/ml) 351 ± 50 ^ 294 ± 40 ab 214 土 28 ^ 
insulin (uU/ml) 4.0 ± 0.2 a 2.1 土 0.3 b 2.8 ± 0.4 ^  
thyroxine (ng/ml) 4.0 土 0.8 ^  13.6 土 0.6。 8.7 ± 0.9 ^  
Na+ (mM) 1 7 8 ± 2 a 1 7 4 ± 2 a 1 6 7 ± 3 匕 
K+ (mM) 6.6 土 0.3 ^  8.0 土 0.2。 14.4 士 0.5 ^  
(1.5 % diet) 
body wt. change (%) -3.6 +15.8 +8.5 
muscle water (%) 73.0 土 0.5 ^  74.0 土 0.4 ^ ^ 75.0 土 0.3 ^  
G H (ng/ml) 20.1 ± 5.0 ^  7.5 ± 2.1 匕 11.0 ± 3.1 ab 
S m C (nM) 6.9 土 1.2， 6.4 土 0/7 ^  7.8 土 1.4 ^  
Cortisol (ng/ml) 281 ± 23 ^ 149 土 24 ^ 105 ± 25 ^ 
I 
insulin (uU/ml) 2.0 土 0.1 a 2.0 土 0.2 ^  5.0 土 0.7 ^  
thyroxine (ng/ml) 6.4 土 0.9 ^  6.0 土 0.8 ^  5.2 土 1.5 ^  
Na+ (mM) 177 ± 1 a 174 ± 2 a 164 ± 2 匕 
K+ (mM) 6.7 土 0.4 ^  9.0 土 0.3。 15.0 土 0.9 ^  
Each group contained 20 fish weighing about 100 g each. Serum levels of hormones 
and ions were measured as described in Materials and Methods. 0.5 % diet = 0.5 g food/ 
100 g fish/ day, 1.5 % diet 二 1.5 g food/ 100 g fish/ day. Percentage body weight change 
=100 % X (body weight of the whole group at the end of the experiment - body weight of 
the whole group at the beginning of the experiment) / body weight of the whole group at 
the beginning of the experiment. G H = growth hormone. S m C 二 somatomedin C. Values 
are expressed as means ± S E M of duplicate determinations. 
a，b，c Within a row of data, values having different superscripts are significantly different 
(based on Duncan's Multiple Range Test at p<0.05 for comparison), 
ab Within a row of data, values having a superscript of ab are not significantly different 
from values having superscripts of either a or b, 
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Discussion 
Increase in the amount of food in the daily diet from 0.5 % to 1.5 % of the body 
weight promoted growth in tilapia in all three salinities. In both types of diet the optimal 
growth rate was observed in 50 % seawater, the poorest growth rate in 100 % seawater and 
the intermediate growth rate in fresh water. Analysis of the muscle water content showed 
that there was only slight dehydration which should not have contributed to the drastic 
change in body weight observed in fish cultured in 50 % seawater and 100 % seawater. It 
suggested that the change in body weight was an index of growth rate. It was initially 
suspected that growth promotion by 50 % seawater and increase in food supply was a result 
of changes in growth hormone secretion in tilapia. Since growth hormone secretion was 
affected in salmon smoltification (Miwa and Inui, 1985; Clarke and Nagahama, 1977a), the 
possible role of growth hormone in seawater adaptation in tilapia was investigated. 
j 
The serum growth hormone level丨 in fish cultured in 50 % seawater was lower than 
I 
the level in fish in 100 % seawater but similar to the fish in fresh water, indicating that the 
highest growth rate in 50 % seawater was not due to an increase in growth hormone 
secretion. On the other hand, the highest serum concentration of growth hormone in fish 
kept in 100 % seawater might be a response of tilapia to osmotic stress and it was not 
reflected in a high growth rate. Helms et al. (1987) found that increase in medium osmotic 
pressure (from 285 or 320 mOsmol to 355 mOsmol) by addition of NaCl significantly 
enhanced release of growth hormone from the tilapia pituitary in vitro. The finding of 
increase in growth hormone secretion after transfer of tilapia to 100 % seawater was 
comparable to the situation of salmon smoltification. Plasma growth hormone level rose 
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during smoltification in coho salmon (Sweeting et al” 1985), Atlantic salmon (Young et al., 
1989) and chum salmon after their introduction into seawater (Hirano et al., 1987: 
Hasegawa et al., 1987). In coho salmon the secretory activity of growth hormone cells in 
i 
the pituitaries increased during smoltification (Clarke and Nagahama, 1977a; Nishioka et 
al., 1982). 
To further investigate the mechanism of optimal growth rate in 50 % seawater, the 
serum concentrations of growth hormone mediator (SmC) and other hormones were 
measured. When the daily food supply was 0.5 % of the body weight (w/w), the highest 
serum S m C level occurred in fish cultured in fresh water, the lowest level in 100 % 
seawater and the intermediate level in 50 % seawater. In the case of fish fed the richer 
(1.5 % ) diet, there were no significant difference in serum S m C level among the 3 groups 
of fish subjected to different ambient salinities. Hence a clear relationship between serum 
S m C level and ambient salinity could not be established because of the absence of a clear 
trend of changes in serum S m C level in tilapia fed the two different diets. Although the 
highest serum concentration of growth hormone was found in the 100 % seawater groups, 
the serum S m C levels in these groups were not higher than those of the other groups, 
suggesting that the high serum concentration of growth hormone did not stimulate S m C 
secretion. As a result, growth was not promoted in that high ambient salinity. There are 
several possible explanations, there might be a defect in the hepatic response of 
somatomedin C production to growth hormone. Hepatic somatomedin C production might 
be regulated by a factor(s) in addition to growth hormone. The serum concentration of 
S m C was not the highest in the 50 % seawater groups which exhibited an optimal growth 
rate. Thus the serum concentration of S m C did not reflect the optimal growth rate. Hence 
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the possible involvement of other hormones in tilapia growth were investigated. 
I 
I 
Lindahl et al. (1985) found that the serum IGF-I/ S m C activity in Baltic salmon was 
higher during smoltification than those prior to and that after the period of smoltification. 
To my knowledge, studies of serum S m C level in non-salmoid fish in relation to seawater 
adaptation have not been attempted. The present study revealed that serum S m C level did 
not show a consistent pattern of changes during seawater adaptation in tilapia and the food 
supply (between 0.5 % to 1.5 % of the body weight) did not affect the serum S m C level. 
It was comparable to the finding by Drakenberg et al. (1989) that starvation of tilapia for 
7 days produced a significant reduction in the body weight without bringing about a 
simultaneous significant change in IGF-I (SmC) activity. The elevation in serum IGF-I/ 
S m C receptor binding activity after the first day of refeeding might reflect the continued 
influence of starvation rather than the direct effect of refeeding. Hence it was unable to 
establish the relationship between nutritional status and serum IGF-I/ S m C level. Although 
a higher growth rate of tilapia receiving the richer (1.5 % ) diet occurred in all 3 salinities, 
growth increased without a simultaneous increase in serum IGF-I (SmC) concentrations 
alone could not account for the increase in somatic growth. 
In fish receiving the 0.5 % diet, the serum concentration of insulin, an anabolic 
hormone, was the highest in the group kept in 100 % seawater. In fish receiving the 1.5 
% diet, the serum insulin level was, however, the highest in the freshwater group. The 
group cultured in 50 % seawater possessed the highest growth rate but the serum insulin 
levels were not the highest. The optimal growth rate achieved in 50 % seawater could not 
be attributed to an increase in serum insulin level. The higher growth rate in fish fed the 
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richer (1.5) diet than that in fish fed the 0.5 % diet similarly could not be explained by a 
higher insulin level. 
Cortisol is a hormone involved in seawater adaptation. It enhanced gill Na+K+_ 
ATPase activity in coho salmon (Bjornsson et al, 1987; Richman and Zaugg, 1977) and 
Atlantic salmon (Langhorne and Simpson, 1986). In the present study, the higher the 
ambient salinity, the higher was the serum concentration of Cortisol. The present 
observation is comparable to the finding that acclimation of carp and tilapia to increasing 
salinities caused an elevation of serum Cortisol level synchronous with an increase in blood 
glucose (Hegab and Hanke, 1984). 
Cortisol facilitates the mobilization of body reserve. Administration of the hormone 
elevated serum glucose and free amino acid levels, oxygen consumption and ammonia and 
potassium excretion rate in intact and hypophysectomized Japanese eel (Chan and Woo, 
1978). The increase in serum glucose level coincided with the increase in serum free amino 
acid concentration and hepatic glutamate-oxaloacetate transaminase (GOT) activity, 
suggesting that the carbon skeleton of glucose was derived from muscle catabolism. This 
I 
protein-catabolic and gluconeogenic effect of Cortisol was important in fish, providing energy 
to the animal during starvation, spawning migration or during stress. In the present study, 
the increase in Cortisol secretion in 100 % seawater favored catabolic processes leading to 
a loss in body weight. On the other hand, a larger food supply (1.5 % of the body weight 
per day) caused a decrease in secretion of Cortisol because more food was now available 
and the mobilization of body reserves became less important. The highest serum level of 
Cortisol in fish cultured in 100 % seawater may probably b e a factor that stimulated the 
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maximal secretion of growth hormone in the fish because Cortisol was found effective in the 
stimulation of in vitro release of growth hormone from the pituitary gland of tilapia 
(Nishioka et al, 1985). 
Thyroxine was shown to enhance larval growth, development and survival in 
Sarotherodon mossambicus (Lam, 1984 & 1985). Thyroxine has also been shown to 
accelerate yolk sac absorption in Sarotherodon niloticus larvae (Nacario, 1983). In the 
present study, only thyroxine was measured because the serum sample size was not large 
enough for triiodothyronine measurement. In fish receiving the 0.5 % diet, the serum 
thyroxine level was the highest in the group kept in 50 % seawater and the lowest in the 
group kept in 100 % seawater. However, in fish receiving the 1.5 % diet the serum 
thyroxine levels were similar in all 3 groups subjected to different salinities. Thyroxine 
stimulated lipid mobilization from liver and muscle in coho salmon parr (Sheridan, 1986). 
Both thyroxine and triiodothyronine increased during smoltification in coho salmon (Young 
et al., 1989). However, in the present study it was impossible to correlate serum thyroxine 
I i 
and seawater adaptation or with the amount of food in the diet. Hence the optimal growth 
rate observed in 50 % seawater could not be due solely to secretion of growth hormone or 
any other hormone investigated above. 
The higher the salinity, the higher was the serum sodium level in fish receiving either 
the 0.5 % or 1.5 % diet. On the other hand, the higher the salinity, the lower was the 
serum potassium level. It suggested an involvement of sodium influx and potassium outflux 
in the osmoregulation of tilapia. Since the optimal growth rate in fish cultured in 50 % 
seawater was not due solely to changes in growth hormone secretion or any other hormone 
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investigated above, a possible factor was osmoregulation. Lam and Sharma (1985) found 
that survival, growth and development of carp larvae (Cypriniis carpio) increased with 
increasing salinity from fresh water to 10 % seawater. Increase in the ambient salinity 
I 
from 1 % to 5 % and 10 % seawater enhanced the effect of thyroxine on C. carpio. In 1 
% seawater, inclusion of thyroxine in seawater at a dose of 0.05 and 0.1 parts per million 
(ppm) significantly stimulated an increase in length and body weight. In 5 % seawater, 
0.05 ppm thyroxine was effective and in 10 % seawater, a lower dose 0.01 ppm of thyroxine 
was sufficient to increase the body weight. 
The optimal growth rate observed in tilapia kept in 50 % seawater was most 
probably due to the fact that at this salinity the osmotic and ionic gradients between the 
internal fluids and the external medium were reduced, so that less energy was expended 
for osmotic and ionic regulation and for maintenance of neutral buoyancy. This hypothesis 
was strengthened by the finding of Bashamohideen et al. (1972) in tilapia fOreochromis 
mossambicus) that oxygen consumption, cytochrome oxidase activity, as well as blood 
glucose level increased while liver glycogen and muscle glycogen content decreased in stress 
media such as 75 % and 100 % seawater. While the lowest blood glucose level and highest 
liver glycogen content were observed in fish cultured in 50 % seawater. These data 
suggested that in tilapia 50 % seawater provided an environment for better growth. 
To sum up the optimal growth rate of tilapia observed in 50 % seawater could not 
be explained by the serum concentration of growth hormone, somatomedin C，Cortisol, 
insulin and thyroxine, the negative growth encountered in the 100 % seawater group could 
not partly attributed to an increase in serum Cortisol concentration. Despite enhanced 
growth hormone secretion in 100 % seawater, there was no concomitant elevation in serum 
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somatomedin C concentration. The serum concentration of insulin and thyroxine were 
unrelated to the negative nitrogen balance observed in 100 % seawater. The increase in 
growth resulting from enrichment of the diet was not accompanied by change of serum 
I 
growth hormone, somatomedin C，insulin and thyroxine but there was a decrease in serum 
Cortisol level. T o further investigate the mechanism of opt imal growth rate in 50 % 
seawater the gill Na+/K+-ATPase activity, serum prolactin level, activities of digestive 
enzyme and rate of transport of nutrients across the gut should be studied. It is because 
the better growth rate in 50 % seawater may be the result of an increased appetite, better 
digestive power or more efficient nutrient transport across the gut. 
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General discussion 
In view of the inadequate supply of tilapia growth hormone and the lack of expertise 
in hypophysectomizing tilapia, the metabolic effects of bovine growth hormone were 
examined in intact tilapia. The ability of the bovine growth hormone to produce a decrease 
in hepatic glycogen content and glycogen synthetase activity is consistent with the 
demonstration of ^ ^^ I-bovine growth hormone binding sites on tilapia liver membranes. The 
somatomedin hypothesis first proposed a mechanism of growth hormone action in the 
mammal may also be applicable to tilapia because the liver was found to be the richest 
source of somatomedin-C-like immunoreactivity in tilapia and the immunoreactivity could 
also be detected in tilapia serum. This somatomedin-C-like immunoreactivity resembled 
the somatomedin-C receptor binding activity detected in tilapia serum by Drakenberg et al. 
(1989) in molecular weight and also in response of body weight changes, thereby confirming 
the presence of somatomedin C-like molecule(s) in tilapia. Changes in somatic growth 
induced by exposure to different salinities or different dietary treatments could be 
accounted for by change in serum Cortisol concentration but not by changes in serum 
concentration of growth hormone, somatOmedin-C, insulin and thyroxine, and it appears that 
！ 
regulation of growth in tilapia is dependent also on factors which have not been examined 
in this study such as energy expenditure of osmotic work and nutrient digestion and 
absorption. The data suggest that growth regulation in tilapia is a complex process. The 
tilapia hepatic growth hormone-binding site has been shown to involved a high M W 
glycoprotein which is acidic in character, similar to its mammalian counterpart. The present 
study constitutes the first report on the partial purification of a teleost growth hormone 
receptor. 
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Results of the present study should provide a basis for further investigation on 
regulation of growth in tilapia. Understanding of the process of growth in teleosts is of 
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